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SUMMARY
In response to a nuclear or radiological emergency, potentially contaminated individu-
als are screened for external contamination[1, 2]. During the screening process, a threshold
screening level is used to triage into two groups: one consisting of those individuals who
need to be decontaminated and the other consisting of those who are either uncontami-
nated or will be given instructions for self-decontamination. Several organizations have
suggested generic contamination levels for this threshold. However, differing assumptions
made during the development of these values regarding the radionuclides present, the dis-
tance between the contaminated surface and the detector, the extent of contamination, the
detector type, etc. have led to potential inconsistencies among the suggested screening
values.
This study uses a modified Phantom with Moving Arms and Legs (PiMAL) phan-
tom and an experimentally verified Geiger-Mueller (GM) pancake probe modeled in the
MCNP6 (Monte Carlo N-Particle 6) transport code to examine the effects of these differing
assumptions on the dose received by a contaminated individual. A 5 µm layer of contami-
nation was modeled to be in direct contact with the epidermis of the phantom. Five sets of
models were created. Each set independently varies either the thickness of the epidermis,
radionuclides comprising the contamination, distance between the probe and the contam-
ination, extent of contamination, or exposure time. The amount of activity assumed to be
present was such that it elicited a detector response of 1000 counts per minute (cpm) for
each model. In each scenario, the relationship between the absorbed dose in a 10 cm2 area





Nuclear and radiological incidents are generally regarded as low-probability, high-consequence
events. Between 1944 and 2000, there were 243 serious accidents in the United States
reported to the Radiation Emergency Assistance Center/Training Site (REAC/TS) Reg-
istry[3]. Instabilities of nuclear states, vulnerabilities of nuclear power plants, availability
of radioactive materials leading to possible terrorism, and growth in industrial use of ra-
dioactivity present the possibility of a nuclear or radiological emergency[4, 5, 6].
In the event of a nuclear or radiological emergency. potentially contaminated individu-
als are screened for external contamination[1, 2]. During this process, screening criteria are
used to delineate those who require decontamination from those who will either be given
instructions for self-decontamination or are not contaminated. Several organizations have
suggested generic screening criteria to be used in such a scenario. However, assumptions
made regarding characteristics of the contamination, the radiation detection instrument,
and the individual being screened has led to inconsistencies among the suggested criteria.
This research focuses on analyzing the effects of variation in assumptions made during
the development of external screening criteria on the dose received by a contaminated in-
dividual during a nuclear or radiological incident. Five factors were evaluated: epidermal
thickness, contamination source, separation between the contaminated skin and the detec-
tor probe, extent of the contamination, and exposure time. Monte Carlo simulations were
used to determine the effect of each factor on the relationship between the detector response




Several organizations have suggested generic screening criteria for external contamination
during radiological and nuclear emergencies. In deriving these suggested criteria, several
assumptions were made regarding characteristics of the detector, the human body, and the
contamination itself. In order to understand the dose a contaminated individual may receive
given a screening value, one must understand the effects of these characteristics on the
relationship between the dose received and the detector response.
2.1 Health Risks Associated with Skin Contamination
The purpose of screening potentially contaminated individuals is to protect the public from
potential mental and physical health effects that could result from skin contamination[7, 8].
The primary goal of screening is to avoid deterministic effects, those effects in which the
severity of the effect is dependent on the dose[1]. All deterministic effects are associated
with a dose threshold below which the effect will not occur. Radiation Emergency Assis-
tance Center/Training Site (REAC/TS) lists dose thresholds of 3 Gy for epilation, 6 Gy for
erythema, 10-15 Gy for dry desquamation, 15-25 Gy for moist desquamation, and greater
than 25 Gy for ulceration [9]. IAEA SRS-02 provides similar dose threshold estimates of
less than 3 Gy for epilation, 3 to 10 Gy for erythema, 8 to 12 Gy for dry desquamation, 15
to 20 Gy for moist dequamation, 15 to 25 Gy for blister formation, and greater than 20 Gy
for ulceration [10].
The secondary goal is to minimize the probability of stochastic effects (e.g. radio-
carcinogenesis). Of the possible stochastic effects, radiation-induced skin cancer is the
primary concern with external contamination. Studies have shown the excess relative risk
of skin cancer incidence to be approximately 10 percent per Sv (0.1 percent per rem) for
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acute doses [9, 11].
2.2 Epidermal Thickness
The human skin is made up of several layers including an outer protective layer of dead or
dying cells referred to as the epidermis[12]. Energy deposited in these dead cells does not
cause any harmful effects to the person. The outermost, exposed layer of the epidermis is
referred to as the stratum corneum. This layer is made up entirely of dead cells which are
pushed to the top and sloughed off. The basal layer, a single layer of cells capable of cell
division, lays directly below the epidermis separating the epidermis from the dermis[12].
This is the outermost layer of viable cells. Unlike the epidermal cells, radiation damage to
these cells can lead to harmful health effects. Below the basal layer lies the dermis, often
referred to as the ”true skin”[12]. Similarly to the basal layer, the dermis contains viable
tissue which is sensitive to radiation. Figure 2.1 depicts the layers of the discussed layers
of the skin.
Figure 2.1: Skin structure
Current dosimetry calculations assume the epidermal thickness to be 70 µm (7 mg/cm2)
[13, 14]. However, this is an oversimplified assumption. Epidermal thickness varies not
only from person to person, but also from one body site to the next [14, 15, 16]. Average
3
epidermal thickness of the trunk has been measured to be 47 µm (4.7 mg/cm2) whereas av-
erage epidermal thickness on the fingertips has been measured to be 406 µm (40.6 mg/cm2).
The thinnest recorded epidermal thickness was found on the temple and measured 17 µm
(1.7 mg/cm2) thick. The thickest recorded epidermal thickness was found on the fingertip
and measured 485 µm (48.5 mg/cm2) thick [14]. However, several sources state that the
sole of the foot is approximately 1400 or 1500 µm [17, 18, 19].
In addition to variations with body site, epidermal thickness on the arms and legs has
been found to increase with age and the epidermal thickness on the face tends to be thinner
in females than in males [14]. Evidence has also been found indicating a variation of epi-
dermal thickness due to environmental factors. The more exposed to the environment the
skin is, the thicker the epidermis becomes[14]. Extended smoking habits correlate to thin-
ner epidermal thicknesses[16]. Additionally, increased pigmentation has been correlated to
increased epidermal thickness[16]. Due to these variations in epidermal thickness, it has
been suggested that 40 µm be considered the average epidermal thickness for dosimetry
calculations rather than the currently assumed 70 µm [15]. For various applications, the
ICRP has applied epidermal thickness from 20 µm to 100 µm in dosimetry calculations
[20]. However, the ICRP recommends the use of 70 µm for general dosimetry calculations,
as the majority of the epidermis is between 50 and 100 µm thick [21].
2.3 Forms of Radiation
Various types of nuclear and radiological incidents will introduce different isotopes with
various forms of radiation into the environment. The ability of a particle to penetrate either
the detector or the epidermal layer of the skin is dependent on the particle type and energy.
2.3.1 Gamma-rays
Gamma-rays lose energy through three interactions, photoelectric effect, Compton scat-
tering, and pair production. In these interactions, the gamma-ray transfers energy to the
4
medium by producing secondary electrons. The secondary electrons produced in gamma-
ray interactions are responsible for the deposited energy in the material.
The photons themselves can travel relatively large distances in matter before interact-
ing. The mean free path of a photon for a given material is defined as the average distance
a photon will travel before interacting in the material. Practically, the energy of a gamma
ray can range from approximately 2.6 keV to 7.1 MeV [22]. In air, this equates to a mean
free path from 0.027 m to 352 m, respectively. In soft tissue, this equates to a mean free
path from approximately 37 µm to 38 cm, respectively. A gamma-ray must have a kinetic
energy of approximately 3.4 keV in order to have a mean free path of 70 µm in soft tissue.
This means that on average, a gamma-ray with 3.4 keV will penetrate a 70 µm epidermis
before interacting. In order to have a mean free path of 17 µm in soft tissue, a gamma-ray
only requires a kinetic energy of approximately 2 keV. Therefore, gamma-rays in the prac-
tical energy range will, on average, penetrate the thinnest epidermal thicknesses prior to
interacting.
2.3.2 Alpha Particles
Alpha particles have a high amount of energy imparted to the medium per unit track length
of the particle, or rather, a high linear energy transfer (LET). Naturally occurring radionu-
clides emit alpha particles with kinetic energies between 4 and 8 MeV[23]. However, the
most common alpha emitters only have kinetic energy between 4.5 and 5.5 MeV[24]. Ap-
plying the Lapp and Andrews alpha particle range equation and the Bragg-Kleman rule, the
range of a common alpha particle in tissue is approximately 30 µm to 41 µm. An alpha par-
ticle requires a minimum of 7.5 MeV to penetrate the average epidermal layer (70 µm)[24].
Therefore, practically, alpha particles will deposit all of their energy within the epidermis,
the dead layer of skin, before reaching viable cells assuming a 70 µm epidermal thickness.
However, for a 17 µm epidermal thickness, an alpha particle only requires a minimum of
approximately 3.2 MeV in order to penetrate through the epidermal layer into the basal
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layer, the outermost layer of viable cells. Practically, alpha particles are not hazardous to
the human body unless they are internalized (inhaled, ingested, etc.). Internalized, alpha
particles deposit large local doses leading to serious health consequences[25]. External
contamination increases the probability of internalization of the contaminant[1].
2.3.3 Beta Particles and Electrons
For beta particles and electrons, LET is inversely proportional to the particle’s energy.
Overall, beta particles and electrons have a relatively low LET. The probability of a beta
particle or electron penetrating the skin is highly dependent on the energy of the particle.
Unlike alpha particles, beta particles emitted from radioactive decay are not monoenergetic,
but rather are emitted within an energy spectrum. The range of a beta particle in a given
media is the expectation value of its total pathlength in the media before depositing the
entirety of its kinetic energy and coming to a rest. The continuous-slowing-down approxi-
mation (CSDA) range is an approximation of the particle’s range assuming that the particle
loses energy at a constant rate. The projected range of the particle in a given medium is the
expectation value of the maximum depth of penetration within the medium.
For low energy electrons, the CSDA range is approximately equivalent to the projected
range of the particle[22]. CSDA range tables indicate that a beta particle requires a kinetic
energy of approximately 70 keV in order to penetrate the average epidermal layer of the
skin (70 µm)[22, 26]. As a rule of thumb, the average energy of a beta spectrum is ap-
proximately equal to one third of the maximum beta energy. However, not all beta spectra
follow the same energy distribution. For example, although the maximum energy of I-131
and Cs-137 beta particles are 807 keV and 1170 keV, repectively, the mean beta energies of
I-131 and Cs-137 are 181 keV and 188 keV, respectively. While a high-energy beta particle
is both an internal and an external hazard, a low energy beta particle will deposit all of its
energy in the epidermis. All beta emitters will produce some beta particles that fall into this
low energy category. Some beta emitters, such as H-3, have a maximum beta energy below
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the minimum energy required to penetrate the epidermis. Similarly to alpha emitters, these
low energy beta emitters are not a hazard unless internalized.
2.4 Geiger-Mueller Detectors
Geiger-Mueller (GM) detectors are commonly available in emergencies due to their sim-
plicity, ease of use, affordability, and widespread use in performing contamination sur-
veys[27, 28].
2.4.1 Detection Efficiency
When setting criteria for portable instruments, one needs to understand the several factors
affecting detection efficiency. Changes in either the intrinsic efficiency and the geometric
efficiency will impact the detector response to radiation.
Intrinsic Efficiency
Intrinsic efficiency is the ratio between the number of pulses recorded and the number of
radiation quanta incident on the detector. The intrinsic efficiency is highly dependent on
the properties of the incident radiation. Only one ion pair must be formed in the fill gas to
spark a Geiger discharge. Therefore, the intrinsic efficiency for charged particles is close to
100 percent. However, due to the low interaction probability of gamma-rays, it is extremely
uncommon for a gamma-ray to interact in the detector fill gas. In order to start a Geiger
discharge, the gamma-ray typically must interact in the detector wall to create a secondary
electron and the secondary electron must reach the fill gas. For this reason, the intrinsic
efficiency for a GM is only a few percent at most for gamma-rays[28].
Geometric Efficiency
Geometric efficiency accounts for all geometric factors. This can include the solid angle
subtended by the detector with respect to the source, interaction with material between the
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source and the detector, backscatter, etc.[29]. When screening for external contamination,
the geometric factor leading to the greatest loss in detection efficiency is the solid angle.
Suggested screening criteria instruct emergency response personnel to hold the probe at
various distances from the potentially contaminated skin surface while screening individ-
uals. This distance can range between 1 cm and 2.54 cm. Response personnel assigned
to screen potentially contaminated individuals typically include volunteers with minimal
training. This often leads to an increase in the distance between the potentially contami-
nated skin surface and the detector probe of several centimeters or more. Typically, man-
ufacturers report the 2π efficiency, the count rate of the detector divided by the activity
emitted in a solid angle of 2π (half of the total activity for an isotropic source)[30].
For this situation, typically the only materials between the contamination and the de-
tector is air and parts of the detector itself, mainly the detector window. As beta particles
are low LET, they can typically pass through the detector window before depositing all of
their energy. However, as previously mentioned, beta decay produces beta particles with a
distribution of energies. Those with low energy will be preferentially absorbed in the de-
tector window, never reaching the fill gas and producing a pulse. Therefore, practical beta
efficiencies are much lower than 100 percent. A few isotopes, such as H-3 and C-14, pro-
duce beta particles with such a low energy spectrum that the large majority of the particles
are absorbed in the detector window causing the detection efficiency to be practically zero.
The detector window of a pancake GM is made of polyethylene terephthalate, also known
as mylar. This material has a low effective mass number, therefore, bremstrahlung creation
in the detector window is insignificant for beta particles and electrons below 10 MeV. As
alpha particles are high LET, there can be significant absorption and backscatter from the
detector window causing a significant drop in the total detection efficiency as the window
thickness increases.
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2.5 Anticipated Exposure Time
The anticipated exposure time, or time that the contamination will remain on the skin, must
also be taken into account. For fixed contamination (contamination that is not cleaned by
repeated washing), the exposure time is assumed to be 14 days after the contamination
incident. This is the estimated time that it will take for a cell at the base of the stratum
corneum, the outermost, dead layer of the epidermis, to reach the surface and be sloughed
off [31, 32]. For loose (removable) contamination, the exposure time is anticipated to be
the time between the contamination event and decontamination by the removal of contam-
inated clothes and washing[1]. In the event of a radiological or nuclear emergency, the
public may be instructed to stay inside for the first 12 to 24 hours while radiation levels
decrease and emergency responders mobilize[33]. This will cause a delay between the
contamination event and the screening and decontamination of potentially contaminated
individuals. Factors such as availability of water, the size of the population involved, or
the availability of instruments can alter the ability to effectively screen and decontaminate
individuals and therefore alter the exposure time for an individual[1]. For example, during
the screening of those affected by the Fukushima accident, responders were faced with dif-
ficulties in obtaining water for decontamination[8]. Therefore, the exposure time for loose
contamination is typically assumed to be between one and two days. The generic screening
criteria suggested by various agencies assumes exposure times of 12 hours, 24 hours, or 36
hours for loose contamination.
2.6 Volume Effects of the Skin
The extent of contamination has two major effects in determining a screening criteria. First,
it can have a great effect on the solid angle and, therefore, a large impact on the detector
efficiency. Secondly, for small irradiation volumes (i.e. skin contamination areas), the
skin displays a volume effect[34, 35, 36]. That is to say, that in comparison to uniform
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contamination over a large skin surface, the skin is able to tolerate larger doses in smaller
volumes before demonstrating a specific health effect. This volume effect is thought to be
caused by the skin’s methods of repairing the damaged area. The current hypothesis is that
there are three repair mechanisms of the skin: migration and division of viable cells from
the basal layer, migration and division of viable cells from hair follicles, and migration and
division of viable cells from the perimeter of the damaged area[34]. The repair of large area
skin injuries is driven by the first two repair mechanisms. The third mechanism is unable to
significantly contribute to repair of large area damage due to the slow pace of cell migration
(approximately 0.2 mm/day)[35, 37]. However, if the damaged area is small enough, the
third mechanism plays a significant role in enabling the skin to repair the damage more
quickly. Therefore, more cells must be damaged in order for a given deterministic effect to
occur.
2.7 Current Suggested Screening Levels
Several organizations have published suggested screening criteria for skin contamination
including Conference of Radiation Control Program Directors (CRCPD), Environmental
Protection Agency (EPA), Federal Emergency Management Agency (FEMA), International
Atomic Energy Agency (IAEA), and National Council of Radiation Protection and Mea-
surement (NCRP). These criteria are summarized in Table 2.1. Some of the suggested
screening criteria are based on minimizing stochastic effects while others are based on
preventing deterministic effects. Inconsistent units are used across organizations, includ-
ing counts per minute (cpm), counts per second (cps), Bq/cm2, dpm/cm2, and Sv/h. They
also use inconsistent terminology. Some have “decontamination level” and “release lev-
els”, while others have “screening values”, “operational intervention levels”, or “required
decontamination levels” and “recommended decontamination levels”. In the derivation of
the criteria, the organizations used differing assumptions as to the detector type, the in-
volved radionuclides, the source-to-detector distance, the extent of the contamination, and
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the exposure time.
2.7.1 Federal Emergency Management Agency (FEMA)
FEMA suggests screening criteria for contamination of the skin during nuclear power plant
accidents. In FEMA-REP-21 it is suggested that an individual with widespread contam-
ination under 1 µCi will not be at significant risk of any detrimental health effects[38].
Furthermore, it is suggested that no more than 10% of this contamination (0.1 µCi) will
be concentrated in a small area (0.2 cm2). FEMA-REP-22 utilizes these values to suggest
screening criteria based on the detector response of portable instruments[39]. FEMA-REP-
22 sets a ‘recommended decision criteria’ of 300 cpm above background for fixed con-
tamination, contamination that is not readily removable, on the skin. If loose and fixed
contamination is present, FEMA-REP-22 recommends a decision criteria of 3,000 cpm
above background. These decision criteria assume the use of a CD V-7001 meter with a
standard side window GM (the least sensitive instrument tested by FEMA). The FEMA-
REP-22 background documentation recommends increasing the decision criteria to 10,000
cpm above background for fixed contamination (100,000 cpm above background for loose
and fixed contamination) when using a modern instrument with a pancake GM probe[40].
It is assumed that the exposure time for loose contamination is 36 hours (12 hours before
monitoring and 24 hours after monitoring) and 14 days for fixed contamination as this is
the approximate time required for the skin to naturally replace itself. The detector hous-
ing is assumed to be one inch away from the skin. FEMA bases the decision criteria on a
Cs-137/Ba-137m source as the average beta energy from this source is similar to the aver-
age beta energy from the predicted mix of radionuclides released in a major nuclear power
accident.
1Manufactured by Nuclear Research Corporation between 1954 and 1955, Victoreen Instrument Company
between 1956 and 1962, International Pump and Machine Works Inc. in 1957, Chatham Electronics in 1957,
Anton Electric Laboratories, Inc. between 1959 and 1960, Lionel Electronic Laboratories between 1960 and
















































































































































































































































































































































































































































2.7.2 Conference of Radiation Control Program Directors (CRCPD)
CRCPD documentation was designed to be used in the event of a radiological dispersal
device (RDD) for the purpose of minimizing the risk of stochastic effects[41]. CRCPD
recommends a release level of 1,000 cpm below which people can be intructed to go home
and shower. In situations involving resource limitations or large populations, CRCPD sug-
gested that the release level may be raised to 10,000 cpm above background. These levels
are meant to be used when measuring 1 inch away from the contamination using a pancake
GM probe. In the derivation of CRCPDs screening criteria, Cs-137/Ba-137m was assumed
to be the radionuclide involved. No exposure time was specified.
2.7.3 Environmental Protection Agency (EPA)
EPA has published several documents in which they present suggested screening criteria,
including Protective Action Guides (PAGs) [42]. Their most recent guidance, 2017 PAG
Manual, recommends a decontamination level of greater than two times the existing back-
ground level and a release level of less than two times the existing background[42]. These
levels are intended to be applicable to any emergency involving a significant release of ra-
dionuclides. They are “derived primarily on the basis of easily measurable radiation levels
using portable instruments.” Although prior guidance from the EPA has assumed the use
of a thin window GM, the latest PAG Manual does not specify the use of any given detec-
tor[43]. Previous guidance has also stated that the screening criteria were derived using an
assumed exposure time of 12 hours before decontamination; however, the latest guidance
from the EPA does not disclose an assumed exposure time. The radionuclides involved,
source to detector distance, and extent of contamination assumed in the development of
this PAG are not specified.
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2.7.4 International Atomic Energy Agency (IAEA)
IAEA presents default values, called Operational Intervention Levels (OILs), above which
specified protective actions are to be taken[44]. OIL4β and OIL4γ provide screening cri-
teria for skin monitoring of beta and gamma radiation, respectively. OIL4β sets a default
screening criteria of 1,000 cps at 2 cm away from the hands and face for beta particles.
The default OIL4β criterion was derived using a baseline beta monitoring instrument, a
beta monitoring instrument with an effective window area of 15 cm2 and an efficiency cor-
responding to the ideal response factors provided in EPR-NPP-OILs 2017, displayed in
Table 2.2. Although this default value is conservatively applicable to any beta monitoring
instruments typically used for beta monitoring on the skin, guidelines are provided to cal-
culate instrument specific OIL4β levels. OIL4γ sets a default screening criteria of 1 Sv/h
at 10 cm away from the hands and face for gamma-rays. Use of OIL4γ is preferred over
OIL4β as it is ‘less dependent on monitoring technique and instrument characteristics.’ In
the derivation of both OIL4β and OIL4γ , all radionuclides that are of concern during an
LWR emergency were considered. IAEA applies a weighting factor of 0.5 to the derivation
of both OIL4β and OIL4γ in order to account for inhalation, ingestion, and operational
practicality. The extent of the contamination and the exposure time assumed in the deriva-
tion are not specified. IAEA also suggests that higher OIL4β and OIL4γ may be used in
situations involving large populations or resource limitations.
2.7.5 National Council on Radiation Protection and Measurements (NCRP)
The NCRP has multiple documents regarding screening criteria.
NCRP Report No. 161
NCRP Report No. 161 is intended to be applicable to a wide variety of incidents in which
people may be contaminated[45]. The screening criteria suggested in this report are in-
tended to be used only in the absence of a screening value provided by the ’national com-
14
Table 2.2: Response Factor of Baseline Beta Monitoring Instrument
(Adapted from EPR-NPP-OILs 2017)










































petent authority.’ Under these circumstances, NCRP Report No. 161 suggests adopting
the 2005 IAEA OILs. In accordance with these OILs, it is suggested that individuals with
contamination below 100 Bq/cm2 be released. Those with contamination between 100
Bq/cm2 and 1,000 Bq/cm2 should be released with instructions to shower and wash their
clothes. This report recommends that the decontamination level be set at 1,000 Bq/cm2,
above which individuals should be decontaminated on site. NCRP Report No. 161 sug-
gests that this decontamination level may be increased; however, it is recommended that
the decontamination level does not exceed 10,000 Bq/cm2. In accordance with prior NCRP
documentation and FEMA-REP-22, this report suggests giving decontamination priority
to any individual with contamination greater than 37,000 Bq on a 0.2 cm2 spot of skin.
NCRP Report No. 161 suggests these values under the assumption that while screening
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an individual, the detector probe is held at a distance of 1 cm from the skin and the probe
is scanned across the skin at a speed of 3 to 5 cm/s. Although not explicitly stated in this
documentation, this screening criteria is based on Sr-90 contamination.
NCRP Report No. 165
NCRP Report No. 165 is intended for use during nuclear and radiological terrorism in-
cidents (RDD, RED, IND, etc.)[46]. In this report, NCRP emphasizes the need to adapt
the screening level in response to the size of the incident. However, the report suggests
an upper limit for the screening level of 600,000 dpm/cm2 for beta/gamma contamination.
Although the assumed exposure time is not stated, in this report the NCRP states that it
should take 6 to 12 hours to establish an appropriate screening center. Although not explic-
itly stated in this documentation, this screening criteria is based on Sr-90 contamination
and the separation between the detector probe and contaminated surface was assumed to be
1 cm.
NCRP Report No. 166
NCRP Report No. 166 is intended to be applied to nuclear or radiological events in which
a population may be exposed, specifically large-scale events[47]. This report suggests a
screening criteria of 1,000 cpm using a pancake probe GM. However, as in NCRP Report
No. 165, this document stresses the need to scale the screening value in response to the size
of affected population. NCRP Report No.166 suggests this criteria under the assumption
that the surveyor is holding the probe approximately 1 cm away from the skin and scanning
at approximately 3 to 5 cm/s. In deriving the suggested screening criteria, Sr-90 was used
as the model contamination source and there was an assumed exposure time of 24 hours, as
it is anticipated that a Federal Radiological Monitoring and Assessment Center (FRMAC)




For this study, four sets of MCNP models were developed. In each set, either the thickness
of the epidermis, the radionuclide present, the separation between the detector probe and
the contaminated surface, or the extent of contamination was independently varied. All
variability models consist of contamination modeled to be in direct contact with the skin
of the phantom and a pancake GM probe positioned so that the detector window faces the
contamination.
3.1 Modified PiMAL Phantom
The female PiMAL Version 4.1 phantom, developed by the United States Nuclear Regu-
latory Commission at Oak Ridge National Laboratory, was utilized in all models of this
study. This phantom has been verified against tabulated dose conversion coefficients in
ICRP Publication 74/ICRU Report 57 as well as computed organ dose values from the
ORNL-UF and MIRD-5 phantoms[48]. The PiMAL phantom was chosen over the ORNL-
UF and MIRD-5 phantoms due to the ease of the user to manipulate the position of the
arms and legs. In each scenario, the phantom was modified to have two layers of skin: a
dermis and an epidermis. The material assigned to both layers is consistent with the orig-
inal phantom; therefore, this modification does not affect the interaction of particles with
the phantom.
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Figure 3.1: 3D view and coronal section of the modified female Phantom with Moving
Arms and Legs (PiMAL) Version 4.1 phantom.
3.2 GM Pancake Probe Model
For the purposes of this study, a GM pancake probe was modeled as the detector. Although
a wide range of detectors could be considered appropriate for contamination screening pur-
poses, pancake GM probes are commonly available. The GM pancake probe model utilized
in this work was modified from a model developed in prior work [49]. The geometry and
materials of the original model were modeled using Ludlum and LND specifications of the
HP-260 Pancake Probe and the Model 44-9 Pancake Probe. The fill gas was modified from
the original model to be composed of Ne, Ar, and Br2 in atomic fractions of 92%, 7.5%,
and 0.5%, respectively. The fill gas pressure was modeled at 0.975 atm as to be in line with
that experimentally determined by Bloch et al. [50].
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3.2.1 Model Verification
Measurements using seven Ludlum Model 44-9 pancake probes with Ludlum Model 3
ratemeters were used to evaluate the accuracy of the MCNP model and simulation of a
GM pancake probe. Two sources were used to verify the model: a NIST traceable sealed
Cs-137 check source and an electroplated Tc-99 source. The Cs-137 source is mounted
on a stainless steel disk, encapsulated in a plastic disk. The stainless steel disk is 0.10
mm thick and 1.27 cm in diameter. The plastic disk encapsulating the stainless steel disk
is 1/8” thick and 1” in diameter. Both sources sit on stainless steel plates inside a plastic
source holders, as shown in Figure 3.2. The exact materials of the holder are unknown.
Therefore, in the Monte Carlo simulation, stainless steel 446 was used as the material com-
position for the metal and polyethylene was used as the material composition for the plastic.
Four measurements were taken with each of the seven probes for each source. For these
measurements, the probe was flush with the open end of the source holder, sitting approx-
imately 3 mm above the source, as shown in Figure 3.3. The same setup was modeled in
the MCNP simulation as can be seen in Figure 3.4. The efficiency was calculated from
the average count rate for each source and compared to the calculated efficiency from the
corresponding MCNP simulation.
3.3 Contamination Model
Air was chosen as the material for the contamination layer for two reasons. First, at the
activity levels of interest for screening criteria, the atomic fraction of radioactive material
is insignificant as compared to the atomic fraction of air in the contamination layer assum-
ing a uniform distribution. Second, modeling the contamination as air provides a more
conservative estimate of the dose deposited per detector response unit.
Several thicknesses of contamination were simulated in order to evaluate the impact of
self attenuation on the relationship between the dose and detector response. The results in-
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Figure 3.2: Tc-99 and Cs-137 source
used for model verification
Figure 3.3: Experimental setup for pan-
cake probe model verification
Figure 3.4: Top: Cross-section pan-
cake probe model verification simulation
setup with Cs-137 source. Bottom: 3D
rendition of HP260 pancake probe model
verification simulation setup
dicated that, at the activity levels in question, the effects of self absorption are insignificant.
Therefore, it was deemed appropriate to model the thickness of the contamination layer as
5 µm.
3.4 Monte Carlo Simulations of Variation Due to Assumed Factors in Suggested
Screening Criteria
3.4.1 Variation in Epidermal Thickness
In order to study the impact of variation in the thickness of the epidermis, a set of five
simulations was created. In each simulation, the thickness of the phantom’s epidermis was
modified. The thinnest epidermal thickness modeled was 17 µm, as this is the thinnest
experimentally reported epidermal thickness (found on the temple). The second simulation
was modified to have a 40 µm thick epidermis; it was recommended by Whitton that this
value should be used as the assumed average epidermal thickness for skin dose control cal-
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culations. In the third simulation, the PiMAL phantom was modified to have a 70 µm thick
epidermis; this is the currently assumed average epidermal thickness in skin dose calcula-
tions. In the fourth simulation, the PiMAL phantom was modified to have an epidermal
thickness of 400 µm as to simulate the average thickness of the fingertips. In the final sim-
ulation of this set, the phantom was modified to have an epidermal thickness of 1500 µm
in order to simulate the average epidermal thickness on the sole of the foot, the location
of the thickest epidermal layer. In each of the models in this set, all other variables (the
radionuclide present, separation between the detector probe and the contaminated surface,
extent of the contamination, and the exposure time) were held at a constant assumed value.
Cs-137/Ba-137m was assumed to be the only radionuclide involved, the exposure time was
assumed to be 36 hours, and it was assumed that the only contamination present was a
0.2 cm2 spot. The location of the detector probe was modified in each model in order to
maintain an assumed separation between the probe and contaminated surface of 1 cm.
3.4.2 Variation in Radionuclide Present
The effects of the beta energy on the relationship between the detector response and the
dose deposited was evaluated with a set of four MCNP simulations. Each one modeled
the contamination as a singular beta emitter: either Tc-99, I-131 , Cs-137/Ba-137m, or
Sr/Y-90. Fission products, I-131, Cs-137, and Sr-90 are three of the main emissions to the
environment from the 1986 Chernobyl Nuclear Power Plant accident[9]. Cs-137 and I-131
were also released during the 2011 Fukishima Daichi Nuclear Power Plant accident and
Cs-137 was the sole contaminant in the 1987 Goiania incident[51]. The beta spectra of
each source was modeled using the ICRP Publication 72 values taken from Radiological
Toolbox Version 3.0.0 developed by Oak Ridge National Laboratory. The maximum beta
energy emitted by Tc-99, Sr-90, I-131, Cs-137, and Y-90 are 294 keV, 546 keV, 807 keV,
1.17 MeV, and 2.28 MeV, respectively. All other variables were held constant across each
model. The epidermal thickness was assumed to be 70 µm, the probe was modeled with a
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separation of 1 cm from the contaminated surface, the exposure time was assumed to be 36
hours, and it was assumed that the only contamination present was a 0.2 cm2 spot.
3.4.3 Variation in Source-to-Detector Distance
Five values of separation between the contaminated surface and the detector probe were
evaluated in this work. The first three values, 1 cm, 2 cm, and 2.54 cm, are each considered
proper screening procedure by at least one of the organization suggesting screening values.
The fourth and fifth values, 5.08 cm (2”) and 7.62 cm (3”), are considered bad practice;
however, it is known that separation of this magnitude often occurs during the screening
process. In each of the models of this set, all other variables were held at an constant
assumed value. The epidermal thickness was held at 70 µm, Cs/Ba-137 was assumed to be
the only radionuclide involved, the exposure time was assumed to be 36 hours, and it was
assumed that the only contamination present was a 0.2 cm2 spot.
3.4.4 Variation in Extent of Contamination
Several simulations were used to evaluate the effects of contamination area on the relation-
ship between detector response and dose to the dermis. For each simulation, the diameter of
the spot contamination was altered. Contamination areas ranged from 0.2 cm2 (the smallest
assumed size of spot contamination due to nuclear fallout) to 25 cm2. In each simulation,
the spot of contamination was centered at the same location on the center of the phantom’s
left forearm. In addition to the spot contamination simulations, a final simulation was run
in which the entire forearm was contaminated. In all simulations, the contamination was
modeled to be uniformly distributed within the designated area.
3.4.5 Variation in Exposure Time
Monte Carlo simulations of each radionuclide examined were used to obtain the initial dose
rate from the contamination as described in Section 3.5. For each of these simulations, a
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0.2 cm2 spot of contamination was present, the detector probe was modeled to be 1 cm
away from the contaminated surface, the epidermis was modeled to be 70 µm thick, and
the activity present was such that it elicited a detector response of 1000 cpm. The total
dose to the dermis was calculated for each radionuclide for exposure times of 12 hours, 24




where Ḋ0 is the initial dose rate as calculated from the Monte Carlo simulation, λ is the
physical decay constant of the corresponding isotope, and t is the exposure time.
3.5 Relationship Between Dose and Detector Response
In each simulation, two tallies were calculated. The first was a pulse height tally, which
provides the energy distribution of the pulses created in the GM. Bloch et al. found that for
the fill gas mixture and pressure used, a minimum of 1.6 keV must be deposited in the gas
to create a pulse. Therefore, the pulse height tally was binned and the portion of the tally
below 1.6 keV was discarded. The integrated remainder of the tally provides the efficiency
to the detector for the geometry and source used in that simulation.
The amount of activity assumed to be present was such that it elicited a detector re-
sponse of 1000 counts per minute (cpm). The activity (dpm) required to produce the as-
sumed count rate was determined as
A = 1000cpm
εcalculated
where εcalculated is the detection efficiency calculated in the Monte Carlo simulation.
A dose volume was defined as a 10 cm2 area centered at the site of the contamination
and extending from the boundary between the epidermis and dermis to the maximum depth
of the dermis. The mass of this volume was calculated with an MCNP simulation. An
energy deposition tally (MeV per source particle) was calculated over the defined dose





where A is the calculated activity in dpm, (E/n) is the average energy deposited per particle




4.1 Pancake Probe Model Verification
The original gamma activity of the Cs-137 source used for the verification measurements
was 1.14±0.057 µCi with an assay date of September 26, 1988. At the time of the measure-
ments, the activity of the sealed Cs-137 source had decayed to 0.58±0.03 µCi. The average
detector reading was 2086±180 cpm. Therefore, the efficiency of the pancake probe was
experimentally found to be 0.16±0.016 % for Cs-137 gamma radiation. The Monte Carlo
model determined the efficiency of the pancake probe to be 0.1204±0.0003 % for Cs-137
gamma radiation.
The original activity of the Tc-99 source used to experimentally validate the pancake
probe model was 0.00558±0.000279 µCi on its assay date of October 10, 1988. At the time
the measurements were taken, the activity of the source remained approximately 0.00558
µCi. The average detector reading was 1542.5±169 cpm. Therefore, the experimentally
determined efficiency of the pancake probe for Tc-99 was 12±1.5 %. The Monte Carlo
model calculated the detection efficiency to be 15.157±0.002 % for Tc-99 beta radiation.
Four factors may have contributed to the error into this simulation. First, statistical er-
ror was introduced by both the experimental decay and the Monte Carlo methods. Second,
several of the experimental materials are protected as proprietary information. Assump-
tions had to made regarding the composition of such materials for the Monte Carlo models.
Energy deposition and scattering is dependent on material composition; therefore, incor-
rectly defined materials could introduce large error in the simulated detection efficiency.
Similarly, error was introduced by simplifications in the MCNP model. The sources were
modeled in air as opposed to on the bench top on which the measurements were taken. The
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geometry of the plastic section of the source tray was also simplified. These simplifications
could reduce the amount of scatter which reaches the detector. Finally, some error may
have been introduced by the model’s imperfect beta spectrum representation. While exper-
imentally a beta spectrum is a continuous probability function, the energy of each source
particle in the MCNP model is sampled from a histogram of beta energies probabilities.
4.2 Variation Associated with Epidermal Thickness
There was no statistically significant change in detection efficiency with increased epider-
mal thickness as can be seen in Figure 4.1. This was expected as neither factors attributing
to the intrinsic detection efficiency nor the geometric detection efficiency were altered.
Figure 4.1: Change in Cs-137/Ba-137m beta detection efficiency, gamma detection effi-
ciency, and total detection efficiency with respect to epidermal thickness
The energy imparted per decay to the defined dose volume for the five simulated epi-
dermal thicknesses are displayed in Table 4.1. As can be seen in Figure 4.2, the energy
imparted decreased approximately exponentially with increasing epidermal thickness. As
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the thickness of the epidermis increases, the more energy beta particles will deposit in the
epidermis before reaching the dermis. Only the most energetic beta particles will have
enough energy to penetrate the epidermis. Those that do manage to reach the dermis will
have less energy to deposit in the viable cells than they would with a thinner epidermis.
Similarly, gamma-rays will be exponentially attenuated as they travel through the epider-
mis. The thicker the epidermis is, the greater the number of gamma-rays that will interact
while passing through it. However, variations in the thickness of the epidermis affect the
energy deposited by beta particles and electrons to a greater extent than the energy de-
posited by gamma-rays.
Table 4.1: Energy deposited per decay vs. epidermal thickness for Cs-137/Ba-137m skin
contamination
Epidermal Thickness (µm) Energy Imparted per Decay (keV)
17 75.66 ± 0.08
40 67.13 ± 0.08
70 58.79 ± 0.07
400 19.46 ± 0.03
1500 4.50 ± 0.014
27
Figure 4.2: Energy deposited in the dermis per decay from Cs-137/Ba-137m skin contam-
ination as a function of epidermal thickness.
The decrease in energy imparted to the dermis with increasing epidermal thickness
drives the relationship between the the dose rate to the dermis and the detector response.
As such, the dose rate decreases approximately exponentially with increasing epidermal
thickness, as seen in Figure 4.3. The data markers in Figure 4.3 are larger than the stated
uncertainty. Table 4.2 presents the dose rate for epidermal thicknesses of 17 µm, 40 µm,
70 µm, 400 µm, 1500 µm assuming that the activity is such that it would elicit a detector
response of 1000 cpm.
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Table 4.2: Dose rate to the dermis vs. epidermal thickness for Cs-137/Ba-137m skin con-
tamination
Epidermal Thickness (µm) Dose Rate (µGy/hr)
17 5.55 ± 0.01
40 4.930 ± 0.009
70 4.315 ± 0.008
400 1.427 ± 0.003
1500 0.3311 ± 0.0006
Figure 4.3: Average dose rate to the dermis from Cs-137/Ba-137m skin contamination
eliciting a 1000 cpm detector response as a function of epidermal thickness
Applying a decontamination screening criteria developed under the assumption that the
epidermis is 70 µm to screening an individual’s trunk (approximately 40 µm) would lead
to an underestimation of the dose by only approximately 12%. However, applying such
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a screening criteria to the face could lead to an underestimation of as much as 22% and
applying the criteria to the fingers and the soles of the feet (approximately 1500 µm) would
lead to an overestimation of up to approximately 202% and 1203%, respectively. This
overestimation could lead to the allocation of time and resources to the decontamination
of individuals whom are not at risk for adverse effects. In setting a screening criteria, one
should also remember that the depth of the epidermis is not uniform within the same body
site or from one individual to the next.
4.3 Variation Associated with Radionuclide Present
The detection efficiencies for Tc-99, I-131, Cs-137, Cs-137/Ba-137m, Sr-90, Y-90, and
Sr/Y-90 are tabulated in Table 4.3 and depicted graphically in Figure 4.4. The data markers
in Figure 4.4 are larger than the stated uncertainty.
As expected, the detection efficiency was dependent on the isotopes present in the con-
tamination. At low energies, the detection efficiency of beta particles increases with energy.
As the energy increases, it becomes more probable that the beta particle will pass through
the detector window into the active volume. However, as the energy continues to increase,
the particle’s LET decreases. As the probability of the particle depositing enough energy in
the active volume to create a detectable pulse decreases, the intrinsic efficiency decreases.
This can be seen in the Y-90 detection efficiency.
Also as expected, a drop in the detection efficiency is seen in the Cs-137/Ba-137m as
compared to Cs-137 due to the low detection efficiency of gamma-rays. In this simulation,
the detection efficiency of the Ba-137m gamma-rays was 0.06976±0.000012%. Therefore,
the detection efficiency of Cs-137 is cut nearly in half with the addition of its Ba-137m
progeny.
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Table 4.3: Detection efficiency vs. contamination radionuclides
Radionuclide Mean Beta Energy (keV) Detection Efficiency (%)
Tc-99 101.2 9.80 ± 0.02
I-131 181.8 10.72 ± 0.014
Cs-137 188.3 10.85 ± 0.02
Cs-137/Ba-137m 188.3 5.90 ± 0.011
Sr-90 195.9 11.06 ± 0.02
Y-90 932.7 9.74 ± 0.02
Sr/Y-90 564.3 10.40 ± 0.02
Figure 4.4: Change in detection efficiency with respect to radionuclides present
The energy imparted to the dermis per decay for Tc-99, I-131, Cs-137, Cs-137/Ba-
137m, Sr-90, Y-90, and Sr/Y-90 is tabulated in Table 4.4 and depicted graphically in Figure
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4.5. The data markers in Figure 4.5 are larger than the reported error. The energy imparted
to the dermis per particle was dependent on the isotopes present in the contamination. This
result was anticipated. The greater the beta energy, the greater the probability that the beta
particle will penetrate the epidermal layer and deposit its energy in the dermis. As can be
seen in Figure 4.5, the Cs-137/Ba-137m and Sr/Y-90 sources depart from this trend. While
Tc-99, I-131, Cs-137, Sr-90, and Y-90 each emit one particle per decay, an increase in the
energy imparted per decay is seen for the Cs-137/Ba-137m and Sr/Y-90 sources due to each
emitting an average of more than one particle per decay.
Table 4.4: Energy deposition per particle vs. contamination radionuclides
Radionuclide Mean Beta Energy (keV) Energy Deposition per Particle
Tc-99 101.2 15.67 ± 0.02
I-131 181.8 47.67 ± 0.03
Cs-137 188.3 53.7 ± 0.07
Cs-137/Ba-137m 188.3 58.69 ± 0.07
Sr-90 195.9 52.4 ± 0.04
Y-90 932.7 262.1 ± 0.2
Sr/Y-90 564.3 314.5 ± 0.2
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Figure 4.5: Change in energy deposition with respect to radionuclides present
Table 4.5 presents the dose rate for Tc-99, I-131, Cs-137, Cs-137/Ba-137m, Sr-90, Y-
90, and Sr/Y-90 spot contamination of the skin assuming that the activity present is such
that a detector response of 1000 cpm would be elicited. This result is depicted graphically
in Figure 4.6. The data markers in Figure 4.6 are larger than the reported error. As one
can see, an increase in energy of the beta particle corresponds to an increase in dose rate in
the dermis. Again, a departure from this trend is seen in the Cs-137/Ba-137m and Sr/Y-90
sources. The increase in the dose rate from Sr/Y-90 as compared to the trend is due to the
two particle emissions for every decay. The increase in dose rate from Cs-137/Ba-137m
as compared to the trend is due to two factors. First, the previously mentioned decreased
efficiency due to the gamma-rays increases the amount of activity required to elicit a 1000
cpm response. Second, similarly to Sr/Y-90, on average, 1.85 particles are emitted per
decay, increasing the energy deposited. Both of these factors increase the dose rate.
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Table 4.5: Dose rate to the dermis from skin contamination corresponding to a 1000 cpm
detector response vs. contamination radionuclides
Radionuclide Mean Beta Energy (keV) Dose Rate (µGy/hr)
Tc-99 101.2 0.692 ± 0.0012
I-131 181.8 1.924 ± 0.003
Cs-137 188.3 2.139 ± 0.004
Cs-137/Ba-137m 188.3 4.305 ± 0.008
Sr-90 195.9 2.050 ± 0.004
Y-90 932.7 11.64 ± 0.03
Sr/Y-90 564.3 12.70 ± 0.02
Figure 4.6: Average dose rate to the dermis from skin contamination eliciting a 1000 cpm
detector response with respect to radionuclides present
If a screening criteria developed around Cs-137/Ba-137m contamination were applied
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for an incident involving Sr/Y-90, a contaminated individual would receive approximately
three times the anticipated skin dose for a given detector reading. Similarly, if one were
to use such a screening criteria in a Tc-99 incident, time and resources would be applied
to decontaminating individuals who would only receive approximately one sixth of the
anticipated skin dose for a given detector reading.
4.4 Variation Associated with Source-to-Detector Distance
The results examining the variation of detection efficiency with change in separation be-
tween the detector probe and the contaminated skin surface are tabulated in Table 4.6 and
displayed graphically in Figure 4.7. The data markers used in Figure 4.7 are larger than the
reported error. As expected, the detection efficiency decreased with increasing separation
between the contaminated surface and the detector probe. Although the overall detection
efficiency for the Ba-137m gamma-rays is lower than the detection efficiency of the Cs-137
beta particles, the variation in separation between the detector probe and the contaminated
surface affects the detection efficiency of the beta particles and gamma-rays to a similar
extent in the range of distances studied.
Table 4.6: Detection efficiency of Cs-137/Ba-137m skin contamination vs. source-to-
detector distance
Separation (cm) Detection Efficiency (%)
1 5.90 ± 0.011
2 3.421 ± 0.009
2.54 2.627 ± 0.008
5.08 0.948 ± 0.005
7.62 0.453 ± 0.003
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Figure 4.7: Change in Cs-137/Ba-137m beta detection efficiency, gamma detection effi-
ciency, and total detection efficiency with respect to source-to-detector distance
As anticipated, there was no statistically significant change in the energy imparted to
the dermis with respect to the separation between the contaminated surface and the detector
probe, as can be seen in Figure 4.8.
Table 4.7: Energy imparted per decay vs. source-to-detector distance for Cs-137/Ba-137m
skin contamination
Separation (cm) Energy Imparted (keV/s.p.)
1 58.69 ± 0.07
2 58.48 ± 0.07
2.54 58.43 ± 0.07
5.08 58.34 ± 0.07
7.62 58.33 ± 0.07
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Figure 4.8: Change in average energy deposited in the dermis from Cs-137/Ba-137m skin
contamination with respect to source-to-detector distance
Therefore, for a set detector response, an increase of dose rate with increasing sepa-
ration between the contaminated surface and the detector probe was observed. The dose
rate for separations of 1 cm, 2 cm, 1”, 2”, and 3” is tabulated in Table 4.8 and displayed in
Figure 4.9. The data markers used in Figure 4.9 are larger than the reported error. These
dose rates assume a detector response of 1000 cpm from Cs-137/Ba-137m contamination.
Similarly to the efficiency, although the overall dose rate from the Ba-137m gamma-rays is
lower than the dose rate from the Cs-137 beta particles, the variation in separation between
the detector probe and the contaminated surface affects the dose rate from the beta particles
and gamma-rays to a similar extent.
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Table 4.8: Dose rate vs. source-to-detector distance for Cs-137/Ba-137m skin contamina-
tion
Separation (cm) Dose Rate (µGy/hr)
1 4.305 ± 0.008
2 7.40 ± 0.02
2.54 9.62 ± 0.03
5.08 26.6 ± 0.2
7.62 55.7 ± 0.4
Figure 4.9: Average dose rate to the dermis from Cs-137/Ba-137m skin contamination
eliciting a 1000 cpm detector response with respect to source-to-detector distance
It should be noted that a separation of 2” or 3” is not recommended; however it is of-
ten observed and, therefore, must be accounted for. For Cs-137/Ba-137m contamination,
in the event a screening criteria designed utilizing a 1 cm separation between the probe
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and skin surface is applied to an individual screened with a separation of 2”, the dose re-
ceived by that individual will be underestimated by approximately 520%. If that individual
is screened with a separation of 3”, the dose received by that individual will be underes-
timated by approximately 1200%. Even among the proper screening techniques, a large
error can be introduced due to variation in the separation between the detector probe and
the contaminated skin surface. Screening with a separation of 1” while using a screening
criteria designed with a separation of 1 cm will underestimate the dose by approximately
120%. Similarly, screening an individual with a separation of 1 cm while using a screening
criteria designed with a separation of 1” will overestimate the dose by approximately 55%
possibly leading to time and resources being allocated to decontaminating individuals who
are below the screening criteria.
4.5 Variation Associated with Extent of Contamination
The Monte Carlo calculated detection efficiency for various contamination areas is pre-
sented in Table 4.9. As can be seen graphically in Figure 4.10, the detection efficiency
decreases linearly with increasing contamination area. This is anticipated as the geometric
efficiency decreases as the contamination area grows.
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Table 4.9: Detection efficiency of Cs-137/Ba-137m skin contamination for a pancake GM
probe with a 15 cm2 window vs. contamination area
Contamination Area (cm2) Detection Efficiency (%)
0.2 5.90 ± 0.011
1 5.83 ± 0.011
2 5.73 ± 0.011
4 5.58 ± 0.011
6 5.37 ± 0.011
8 5.208 ± 0.008
10 5.07 ± 0.010
12 4.90 ± 0.010
14 4.74 ± 0.010
16 4.59 ± 0.010
18 4.44 ± 0.010
20 4.287 ± 0.009
25 3.922 ± 0.009
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Figure 4.10: Change in Cs-137/Ba-137m beta detection efficiency, gamma detection effi-
ciency, and total detection efficiency with respect to extent of contamination. The area of
the detector window (15 cm2) is indicated with the vertical dotted line.
The energy imparted to the dermis per particle is tabulated in Table 4.10. As can be
seen in Figure 4.11, the energy imparted per particle remains stable for small contamina-
tion areas. As the contamination area approaches the size of the dose volume, the energy
imparted per particle begins to decrease. This is expected as beta particles created in the
periphery of the contamination area begin to scatter out of or never reach the dose volume
before depositing all of their energy.
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Table 4.10: Energy imparted per decay vs. contamination area for Cs-137/Ba-137m skin
contamination
Contamination Area (cm2) Energy Imparted per Particle (keV)
0.2 58.69 ± 0.07
1 58.65 ± 0.07
2 58.51 ± 0.07
4 58.50 ± 0.07
6 58.33 ± 0.07
8 58.24 ± 0.07
10 57.78 ± 0.07
12 50.22 ± 0.07
14 43.25 ± 0.06
16 37.98 ± 0.06
18 33.86 ± 0.06
20 30.48 ± 0.05
25 24.42 ± 0.05
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Figure 4.11: Change in energy imparted per decay from Cs-137/Ba-137m skin contamina-
tion with respect to extent of contamination. The vertical dashed line represents the area of
the defined dose volume (10 cm2).
The calculated dose rates with respect to extent of contamination are presented in Table
4.11. As can be seen in Figure 4.12, the dose rate increases with contamination area until
a maximum dose rate is reached at approximately 10 cm2, the area of the dose volume.
At points within this boundary, although the energy imparted per particle is decreasing, it
remains relatively steady as compared to the detection efficiency. Therefore, the dose rate
is driven by its inverse proportionality to the detection efficiency. Beyond this boundary,
the dose rate decreases dramatically. This is expected as at this distance, electrons created
in the periphery of the contamination area no longer contribute dose to the defined dose
volume.
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Table 4.11: Dose rate vs. contamination area for Cs-137/Ba-137m skin contamination
Contamination Area (cm2) Dose Rate (µGy/hr)
0.2 4.305 ± 0.008
1 4.355 ± 0.008
2 4.416 ± 0.008
4 4.538 ± 0.009
6 4.698 ± 0.009
8 4.838 ± 0.008
10 4.93 ± 0.010
12 4.431 ± 0.009
14 3.945 ± 0.008
16 3.582 ± 0.008
18 3.302 ± 0.007
20 3.076 ± 0.007
25 2.693 ± 0.006
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Figure 4.12: Average dose rate to the dermis from Cs-137/Ba-137m skin contamination
eliciting a 1000 cpm detector response with respect to extent of contamination. The vertical
dashed line represents the area of the defined dose volume (10 cm2). The area of the
detector window (15 cm2) is indicated with the vertical dotted line.
It is expected that as the contamination volume continues to grow, the detection effi-
ciency and the energy imparted will begin to decrease at similar rates. This will cause the
dose rate to stabilize at a minimum dose rate. For the simulation in which contamination
encompasses the entirety of the forearm (widespread contamination), the dose rate was
calculated to be 1.88±0.02 µGy/hr. Assuming the dose rate has stabilized at this point, uti-
lizing a screening criteria developed for widespread contamination for spot contamination
could lead to underestimation of the absorbed dose by up to a factor of 2.6. This result
accounts only for the effects of variation in the extent of contamination on the relationship
between the detector response and the dose to the dermis. It does not account for volume
effects due to skin repair mechanisms.
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4.6 Variation Associated with Exposure Time
The absorbed dose for 12 hour, 24 hour, 36 hour, and 14 day increments for each radionu-
clide simulated is tabulated in Table 4.12.
Table 4.12: Absorbed dose from Cs-137/Ba-137m skin contamination eliciting a 1000 cpm




12 hours 24 hours 36 hours 14 days
Tc-99 8.30±0.01 16.61±0.03 24.92±0.04 232.5±0.4
I-131 22.60±0.03 44.25±0.06 64.98±0.08 375.0±0.5
Cs/Ba-137 51.7±0.10 103.3±0.2 155.0±0.3 1446±3
Sr/Y-90 152.3±0.2 304.7±0.4 457.0±0.7 4264±6
As can be seen graphically in Figure 4.13, the decrease in activity over the exposure
time is negligible for Tc-99, Cs-137/Ba-137m, and Sr/Y-90. As such the dose rate remains
stable providing an approximately linear relationship between exposure time and absorbed
dose. Unlike the other radionuclides, I-131 has a relatively short half-life in comparison
to the exposure time. As such, the decrease in activity over a 14 day period is no longer
negligible and the linear relationship between exposure time and dose is no longer valid.
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Figure 4.13: Change in absorbed dose to the dermis from skin contamination eliciting a
1000 cpm response at 1 cm with respect to exposure time
Applying a screening criteria developed under the assumption of a 12 hour exposure
time to a situation in which there will be a 36 hour exposure time could lead to an un-
derestimation of the dose by a factor of approximately three for each of the four isotopes
examined in this study.
4.7 Comparison of Variation in Assumed Factors
In Figure 4.14, the variation in dose rate with respect to each previously discussed factor
assuming a detector response of 1000 cpm is shown. Variations in epidermal thickness,
contamination radionuclide, and separation between the detector probe and the contami-
nated surface have an approximately equal relative effect on the relationship between the
absorbed dose to the dermis and the detector response. As can be seen by the graph, vari-
ation in the separation between the detector probe and the contaminated surface has the
greatest absolute effect on the relationship between the absorbed dose to the dermis and
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Figure 4.14: Top left: Change in average dose rate to the dermis from Cs-137/Ba-137m
skin contamination eliciting a 1000 cpm detector response with respect to epidermal thick-
ness. Bottom left: Change in average dose rate to the dermis from Cs-137/Ba-137m skin
contamination eliciting a 1000 cpm detector response with respect to source-to-detector
distance. Top right: Change in average dose rate to the dermis from skin contamination
eliciting a 1000 cpm detector response with respect to contamination source. Bottom right:
Change in average dose rate to the dermis from Cs-137/Ba-137m skin contamination elic-
iting a 1000 cpm detector response with respect to contamination extent.
the detector response. However, within the range of proper scanning technique, the sep-
aration between the probe and the contaminated surface accounts for the least degree of
variability in the relationship between detector response and dose to the dermis. Assum-
ing proper scanning technique is applied and accounting for the fact that only a select few
radionuclides were examined in this research, variation of the radionuclides involved in
the contamination provide the greatest range of variability in the relationship between the
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detector response and the absorbed dose to the dermis.
4.8 Comparison of Suggested Screening Criteria
The suggested screening criteria can be compared by applying them all to the same hypo-
thetical incident. Let us assume that an individual with a 0.2 cm2 spot of loose Cs/Ba-137
contamination is being screened with a pancake probe. We will assume that for each sce-
nario, the spot contains an activity eliciting a detector response equivalent to the screening
criteria and that the separation between the probe and contaminated surface used is that
dictated by the screening criteria. As the screening criteria suggested by the EPA does not
provide a suggested separation between the probe and the contaminated surface, 1” will
be assumed. As the screening criteria suggested by the EPA is based on the current back-
ground, it will be assumed that the background is elevated to 50 cpm. It will be assumed
that 36 hours will pass between the contamination event and the time of decontamination,
i.e. the individual will be exposed for a total of 36 hours. The volume averaged absorbed
dose to the dermis is presented in Table 4.13 for each screening criteria.
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Table 4.13: Absorbed dose from Cs-137/Ba-137m spot contamination with the direct ap-










2.54 10,000 cpm 3460±11
FEMA-REP-22 (CD
V-700)
2.54 300 cpm 103.8±0.3
CRCPD Handbook 2.54 10,000 cpm 3460±11
EPA PAG Manual 2.54 2× background 17.32±0.015
IAEA EPP-NPR-OILs
2017 (OIL4β)
2 1,000 cps 15980±40
IAEA EPP-NPR-OILs
2017 (OIL4γ)
10 1 µSv/h 3490±30
NCRP Report No. 161 1 10,000 Bq/cm2 1097±0.0002




NCRP Report No. 166 1 1,000 cpm 155.0±0.3
As can be seen in Table 4.13, the 2017 EPA PAG Manual provides the most conservative
screening criteria for spot contamination. However, this result can be misleading as the EPA
bases their suggested screening criteria on the present background. As the background
increases, the screening criteria suggested by the EPA becomes less conservative. The
results in Table 4.13 indicate that IAEA provides the least conservative screening criteria,
OIL4β . For the given situation, OIL4β leads to a dose approximately 360% higher than
the second least conservative criteria, provided by OIL4γ ,FEMA-REP-22, and the CRCPD
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Handbook. However, both FEMA-REP-22 and the CRCPD Handbook recommend that
the screening criteria be reduced to 1,000 cpm for fixed contamination. In which case the
absorbed dose resulting from these criteria would be decreased to 10% of that shown in
Table 4.13, further increasing the dose difference. It should also be noted that the dose
reported in Table 4.13 corresponding to OIL4γ assumes that there is no beta shield applied
to the detector probe. If a beta shield were applied to the detector probe, OIL4γ could lead
to a dose of close to 0.5 Gy in this scenario (a dose approximately 3,000% greater than
that resulting from OIL4β). As it stands, applying the suggested screening criteria to the




CONCLUSION AND FUTURE WORK
This work evaluated the impact of five factors on the relationship between detector re-
sponse and absorbed dose during a nuclear or radiological emergency. The results indicate
that variations in any of the five factors (epidermal thickness, contamination radionuclide,
source-to-detector distance, contamination extent, and exposure time) could greatly impact
the relationship between the detector response and the skin dose due to external contami-
nation. It is clear that for a given external contamination screening criterion, the resulting
skin dose can vary significantly depending on the nature and distribution of contamination
on the skin and the survey technique. The application of these results along with future
work to emergency planning may aide in adjusting screening levels based on the specific
circumstances of the situation at hand.
Only one detector type was evaluated in this work. Several detector options may be
available to first responders including EPDs, ion chambers, and other types of GM probes.
Future research should expound on these findings to include the evaluation of variation due
to characteristics of the contamination and survey techniques with alternate detector types.
Only four isotopes were evaluated as the contaminant in this work. Future work should
include the evaluation of several additional isotopes likely to become external contamina-
tion in the event of a nuclear or radiological emergency. These isotopes should include
alpha emitters in addition to beta and gamma emitters.
Finally, additional factors should be accounted for in choosing an appropriate screening
criteria. These factors include accounting for the probability of internalization of external





SAMPLE MCNP INPUT FILE
Mathematical FEMALE Phantom model
C ===================================================================
c 0.2 cm2 spot source on left forearm
c GM 1 cm from left forearm
c ===================================================================
c ===== Posture Parameters Angles are in degrees
C ===== Posture Parameters Right shoulder rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Right ellbow rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Left ellbow rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Right hip rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Left knee rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Right knee rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Left shoulder rotation:Theta = 0 Phi = 0
C ===== Posture Parameters Left hip rotation:Theta = 0 Phi = 0
C ===================================================================
C ====== The Female model is based on the 15 yr Hermaphrodite





C ========= Description of Input File ===============================
C ===================================================================
C ===== Cell numbers 1-132 are used to describe the phantom and
C ===== 133 is used to describe surrounding around the phantom, which
C ===== is set to vacuum at the moment.
C ===== Surface numbers 1-338 are used to describe the phantom
C ===== and outside.
C ===== Material number 1-25 are allocated to describe phantom
C ===== materials.
C =====
C ===== Therefore, it is important to use
C ===== Cell Number ¿ 135
C ===== Surface Number ¿ 339
C ===== Material Number¿ 26
C ===== to define new cells, surfaces, materials when needed for
C ===== modification towards adding new objects.
C ===== When new objects are added, make sure to modify the importance












C 1.1 The Skin of Head and Neck
C ===================================================================
C
1 11 -1.09 ((-8 9):-7)-1 12 (2:4:7:(-6 11))
(5:(-10 11):-12)(-5:7:-4:(-13 85 14)
:(2 -1 -14)) #7 #8 #2
VOL=214.8
C ===================================================================
C 1.2 The Cranium
C ===================================================================
C
2 2 -1.4 (15 -19 7):(16 -20 17 21 -7):(-20 -17 21 -7)
VOL=284.5
C ===================================================================
C 1.3 The Teeth
C ===================================================================
C
3 2 -1.4 -22 23 24 -25 -26 VOL=30.2
C ===================================================================
C 1.4 The Mandible
C ===================================================================
C
4 2 -1.4 (-27 29((28 -24 -26):(30 -21 26 -18)))
VOL=144.8
C ===================================================================
C 1.5 Nasal Cavity (The Upper Face Region, Facial skeleton)
C ===================================================================
C
5 5 -1.22 -31 25 -21 -26 32 33
C
C remove sphenoid Sinus
(39 40)
C remove ethmoid Sinus
(41 42)
C remove frontal Sinus
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(43 44)





C 1.7 The Brain
C ===================================================================
C
6 6 -1.04 (7 -34):(-7 -35 36) VOL=1310.2
C ===================================================================
C 1.8 The eyes
C ===================================================================
C Left
7 7 -1.07 -32 VOL=6.2
C Right
8 7 -1.07 -33 VOL=6.2
C ===================================================================
C 1.9 Total Sinuses
C ===================================================================
C
9 4 -0.001205 (-39:-40:-41:-42:-43:-44:-45:-46)
VOL = 33.12171220
C ===================================================================























































19 10 -1.05 (339 -5 66 -59 60 -61 -65):
(-339 -5 66 -59 60 -62 -65):
(339 67 -66 -59 60 63 -65 (53 : 55)):








20 4 -0.001205 -68 -69 73 1 -76
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21 13 -1.05 -71 -72 73 1 -76 (-75:69)(74:68)
Vol=6.865
C ===================================================================
C 1.18 Oral Cavity (Soft tissue Behind mouth and teeth)
C ===================================================================
C
22 12 -1.03 (((-30 29 -21 26 -18)
:(-26 -23 24 -25)
:(-26 -28 -24 29))




C 1.19 Salivery Glands
C ===================================================================
C Left & Right Parotid
C ===================================================================
C
C 51 1 -1.04 (-636 : -641) 531 -565
C Vol = 38.462
C
C Left & Right Submandibular
C
C 53 1 -1.04 (-637 : -642) -638 536
C Vol = 19.296
C
C Left & Right Sublingual
C
C 55 1 -1.04 (-639 : -643) 640 -533 -535
C Vol = 7.692
C
C Total Salivery Glands
C
23 12 -1.03 (((-77 : -78) 24 -49):((-79 : -81) -80 29):
((-82 : -84) 83 -26 -28))
Vol = 65.385
C ===================================================================












C remove nasal cavity
(31:-25:21:26:-32:-33)














C remove Oral Cavity
#22










C 2.1.1 Cervical Verterbra - CV(upper)
C ===================================================================
C
25 2 -1.4 -85 -89 88 VOL=130.626
C ===================================================================




26 2 -1.4 -85 -88 87 VOL=418.90
C ===================================================================
C 2.1.3 Lumber Verterbra - LV (lower)
C ===================================================================
C





28 2 -1.4 91 -90 ((93 -92):(95 -94):(97 -96):(99 -98):
(101 -100):(103 -102):(105 -104):(107 -106):(109 -108):























C =============== 3.0 Upper Chest Organs ===========================
C
C ===================================================================






















35 14 -0.26 -154 156 (163:162:161) VOL=1020
C right









C Wall of heart
C ===================================================================
38 15 -1.05 (165 ((-166 168 -167):(170 -169))):




C Contents of heart
C ===================================================================
39 15 -1.05 (165 ((-166 -168 169):(-170))):












40 12 -1.03 179 -177 VOL=5.05
C right






42 16 -1.04 (-180 182) VOL=119.2
C right kidney
C




44 17 -1.05 -204 -205 207 -206 VOL=1350
C
C ===================================================================
C 4.4 Gall bladder
C ===================================================================
C wall
45 12 -1.03 (-212 208 -209):(212 -213 210 -211)
VOL=7.61609
C contents














C =============== 5.0 Gastrointestinal tract and contents ==========
C
C ===================================================================
C 5.1 Male Esophagus /*** 1996 ORNL C&E ***/
C ===================================================================




49 12 -1.03 (-220 222 206 -88)
VOL = 5.13853867
C ===================================================================
C Mucosa Wall of the abdominal portion
C ===================================================================
50 12 -1.03 (-219 224 -225)
VOL = .1088341717
C ===================================================================
C Remainder Wall of the thoracic and abdominal portion
C ===================================================================
51 12 -1.03 (-221 220 206 -88):(-223 219 224 -225)
VOL= 26.4836
C ===================================================================
C Contents of the thoracic portion
C ===================================================================
52 4 -0.001205 -222 206 -88 VOL=7.065490673
C ===================================================================
C













55 20 -1.03 -228 VOL=187
C ===================================================================
C
C =============== 5.3 S. intestine ================================
C
C ===================================================================
56 20 -1.03 -128 230 -231 232 -207
C
C remove a. colon
(235:238:-232)
C remove t. colon
(240:242:-243)
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C 5.4 Right colon *
C ===================================================================
C 5.4.1 A. colon
C Mucosa Wall
C
57 20 -1.03 (-234 236 237 -238) VOL = 16.90747038
C ===================================================================
C Remainder Wall
58 20 -1.03 (-235 234 237 -238) VOL = 52.59252962
C ===================================================================
C Contents
59 20 -1.03 (-236 237 -238) VOL = 73.4
C ===================================================================
C












62 20 -1.03 -241 -242 243 -339 VOL = 48
C ===================================================================
C
C 5.5 Left colon













65 20 -1.03 -241 -242 243 339 VOL = 48
C ===================================================================












68 20 -1.03 (-246 247 -238) VOL = 58.93
C
C ===================================================================
C 5.6 Rectosigmoid *
C ===================================================================
C


































C ====== 6.0 Lower Chest Organ ====================================
C
C ===================================================================






























78 23 -1.05 -272 VOL=5.05
C right
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81 25 -0.94 -276 342 VOL=235.921
C right gland
82 25 -0.94 -277 342 VOL=235.921
C
C ===================================================================
C 9.0 Muscle in the Trunk
C ===================================================================
C










C remove clavicles (left / right)
(116:-117:119) (116:118:-120)





C remove main bronchi
(144:146:-147:57:-154:-339)(148:150:-151:57:-155:339)
C remove lungs (left / right)
(154:92:-156:(-163 -162 -161))






C remove adrenals (left / right)
(177:-179) (178:-179)














C remove s. intestine
(128:-230:231:-232:207)
C remove a. colon
(232:235:-237)
C remove d. colon
(232:245:-247)
















C 10.2.2 Skin of Female Trunk (includes BREAST)
C ===================================================================
C
84 11 -1.09 ( (-278 +342 -343 +344 -88 +341):
(-278 +10 -345 +346 -283 +88):
(-278 -345 +343 -88 +341):
(-278 -344 +346 -88 +341):
68
C plus breast part
(342 ((-279 276):(-280 277))))
C remove material under neck
(10:-88:283)







C ARMS and LEGS for PIMAL
C ===================================================================
C ======== RIGHT ARM —- BONE
85 2 -1.4 -289 +290 +294
86 2 -1.4 -290 +291
87 2 -1.4 -291
88 2 -1.4 -292 +291 +290
C ======== RIGHT ARM — SOFT TISSUE
89 13 -1.05 -293 +289 +290 +294
90 13 -1.05 -294 +290 +292
91 13 -1.05 -295 +290 +291 +292 +294 +296
92 13 -1.05 -296 +292 +294
C ======== RIGHT ARM — SKIN
c 93 11 -1.09 -297 +293 +294 +298
c 94 11 -1.09 -298 +294 +296
c 95 11 -1.09 -299 +294 +295 +296 +298 +300
c 96 11 -1.09 -300 +296 +298 +295
C
C ======== LEFT ARM —- BONE
97 2 -1.4 -301 +302 +306
98 2 -1.4 -302 +303
99 2 -1.4 -303
100 2 -1.4 -304 +303 +302
C ======== LEFT ARM — SOFT TISSUE
101 13 -1.05 -305 +301 +302 +306
102 13 -1.05 -306 +302 +304
103 13 -1.05 -307 +302 +303 +304 +306 +308
104 13 -1.05 -308 +304 +306
C ======== LEFT ARM — SKIN
c 105 11 -1.09 -309 +305 +306 +310
c 106 11 -1.09 -310 +306 +308
c 107 11 -1.09 -311 +306 +307 +308 +310 +312




c ======= RIGHT LEG — BONE
109 2 -1.4 -313 -341
110 2 -1.4 (-314 -341 315 313 ):(341 -314 315 313 278 )
111 2 -1.4 -315
112 2 -1.4 -316 315 314
c ======= RIGHT LEG — TISSUE
113 13 -1.05 -317 -341 313 314 334
114 13 -1.05 (-318 314 315 316 317 -346 ):(346 -341 -318 315 314 316 317
):(-318 314 315 316 317 341 278 )
115 13 -1.05 -319 314 315 316 318 320
116 13 -1.05 -320 316 318
c ======= RIGHT LEG — SKIN
117 11 -1.09 -321 -341 322 317 334
118 11 -1.09 (-322 318 319 320 317 -346 ):(346 318 319 320 317 -322 -341
):(-322 318 319 320 317 341 278 )
119 11 -1.09 -323 318 319 320 322 324
120 11 -1.09 -324 319 320 322
c
c
c ======= LEFT LEG — BONE
121 2 -1.4 -325 -341
122 2 -1.4 (-326 -341 327 325 ):(-326 341 278 327 325 )
123 2 -1.4 -327
124 2 -1.4 -328 327 326
c ======= LEFT LEG — TISSUE
125 13 -1.05 -329 -341 325 326 322
126 13 -1.05 (-330 326 327 328 329 345 ):(326 -330 327 328 329 -345 -341
):(-330 326 327 328 329 341 278 )
127 13 -1.05 -331 326 327 328 330 332
128 13 -1.05 -332 328 330
c ======= LEFT LEG — SKIN
129 11 -1.09 -333 -341 334 329 322
130 11 -1.09 (-334 330 331 332 329 345 ):(-334 330 331 332 329 -345 -341
):(-334 330 331 332 329 341 278 )
131 11 -1.09 -335 330 331 332 334 336






c ======== Head and Neck
c ——– top of the head ———
501 33 -0.0012 (-508 8 7)
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c ——– face —————
1501 33 -0.0012 ((-501 -4 32 33 -7 ((1 5):(-5 505 10))) #21 #20)
c —— back of the head ——-
2501 33 -0.0012 ((-513 13 85 505 4 -7): (-501 1 -13 -7 4 505))
c ———– neck ————
3501 33 -0.0012 (-505 -510 10 512 283)
c ======== Nose
521 33 -0.0012 ((-571 -572 73 501 -76 -75 71)
:(-571 -572 73 501 -76 74 72))
c ======== Trunk
c —– Trunk ————-
584 33 -0.0012 (((-778 278 -345 346 -283 341):
(-778 -845 345 -283 341):
(-778 -346 846 -283 341))
c remove material under neck
(510:-283:783)
c remove material under breast area (left/right)
(-278:778:279) (-278:778:280) 780 779
c remove material inside arms
(298 310))
c ——— top of trunk ——–
684 33 -0.0012 (-778 510 -845 846 -783 283)
c ——— breasts ———–
784 33 -0.0012 (278 (-779 279))
884 33 -0.0012 (278 (-780 280))
c ==========Arm
c ———- Right Arm ——–
593 33 -0.0012 (-797 297 298 798)
594 33 -0.0012 (-798 298 300 -846)
595 33 -0.0012 (-799 298 299 300 798 800)
596 33 -0.0012 (-800 300 798 299)
c ———- Left Arm ———-
605 33 -0.0012 (-809 309 310 810)
606 33 -0.0012 (-810 310 312 845)
607 33 -0.0012 (-811 310 311 312 810 812)
608 33 -0.0012 (-812 312 810 311)
c ========== Legs
c ———- Right Leg ————
617 33 -0.0012 (-821 -341 822 321 834)
618 33 -0.0012 ((-822 322 323 324 321 -346)
:(346 322 323 324 321 -822 -341)
:(-822 322 323 324 321 341 778))
619 33 -0.0012 (-823 322 323 324 822 824)
620 33 -0.0012 (-824 323 324 822)
c ———– Left Leg ————-
71
629 33 -0.0012 (-833 -341 834 333 822)
630 33 -0.0012 ((-834 334 335 336 333 345)
:(-834 334 335 336 333 -345 -341)
:(-834 334 335 336 333 341 778))
631 33 -0.0012 (-835 334 335 336 834 836)




c ————- Arms ———————–
1093 11 -1.09 -793 293 294 298
1094 11 -1.09 -794 294 296
1095 11 -1.09 -795 294 295 296 298 300
1096 11 -1.09 -796 296 298 295
2093 11 -1.09 -297 793 294 298
2094 11 -1.09 -298 794 796
2095 11 -1.09 -299 294 795 296 298 300
2096 11 -1.09 -300 796 298 295
1105 11 -1.09 -805 305 306 310
1106 11 -1.09 -806 306 308
1107 11 -1.09 -807 306 307 308 310 312
1108 11 -1.09 -808 308 310 307 900
2105 11 -1.09 -309 805 306 310
2106 11 -1.09 -310 806 808
2107 11 -1.09 -311 306 807 308 310 312




801 31 -0.0008698 -401:-415 $fill gas
802 32 -7.8 -416 401 415:-417:-418 419 $ steel casing
803 33 -0.0012 -403:-406 420 421 422 423 424 425 426 427 428 429 430 431 432
433 434 435 436 437 438 439:-407 402 415 416 417 418 419:-409 419
$air
804 34 -2.6989 -405 402 403 406 407 420 421 422 423 424 425 426 427 428 429 430
431 432 434 435 436 437 438 439 416:-408 407 409:-410 409 407:-420:-
421
:-422:-423:-424:-425:-426:-427:-428:-429:-430:-431:-432:-433
:-434:-435:-436:-437:-438:-439 $ aluminum mesh
805 35 -0.94 -411:-412:-413:-414 $ poly
806 36 -8.96 -419 $ copper wire
c add cell 807 to cell 133 and change cell 133 to air
c 807 33 -0.0012 -199 105 106 108 110 111 112 113 114 119 150 160:-151 153 160
c :-152 151:-154 160 $air




2900 11 -1.09 -900 -808 308
C ===================================================================
C Air Around the phantom
C ===================================================================
C
133 33 -0.0012 -338
C remove head and neck
((1:-12:(8 7)):(1:-12:(-5 10 12))
:(1:-12:(4 -7 5 13)))
C remove nose
(71:72:-73:-1:76)
C remove trunk region
(-341:278:283:-346:345)
C remove breast region
(-278:(279 280))
+297 +298 +299 +300 +309 +310 +311 +312 $Exclude Arms
+321 +322 +323 +324 +333 +334 +335 +336 $Exclude Legs
405 406 408 410 411 412 413 414 419 $Excludes GM
c exclude head and neck contamination
((501:-12:(508 7)):(501:-12:(-505 510 512)):(501:-12:(4 -7 505 513)))
c exclude nose contamination
(571:572:-73:-501:76)
c exclude trunk contamination
(-341:778:783:-846:845)
c exclude breast contamination
(-778:(779 780))
c exclude arm contamination (left/right)
(797 798 799 800) (809 810 811 812)
c exclude leg contamination (left/right)
(821 822 823 824) (833 834 835 836)
C
C ===================================================================













C 1.0 Head and Neck Region
C ===================================================================
c
C 1.1 The skin of head
C
C Skin in the Face *
C ===================================================================
C
1 SQ 0.017313 0.011317 0 0 0 0 -1 0 0 0







C Skin in the TOP OF the Head *
C ===================================================================
8 SQ 0.017313 0.011317 0.030036 0 0 0 -1 0 0 80.22
9 SQ 0.018114 0.011738 0.031888 0 0 0 -1 0 0 80.22
C ===================================================================
C Skin in the Neck*
C ===================================================================
10 SQ 1 1 0 0 0 0 -25.0000 0 1.78 0
11 SQ 1 1 0 0 0 0 -23.3289 0 1.78 0
12 PZ 63.1
C ===================================================================
C Skin in the BACK of the head*
C ===================================================================
13 K/Z 0 1.78 42.64351145 .4112231498e-1
14 K/Z 0 1.78 43.96522901 .4222622069e-1
C ===================================================================
C 1.2 The Cranium
C ===================================================================
C
C Cranium Inner Surface
15 SQ 0.020525 0.012972 0.037704 0 0 0 -1 0 0 80.22
16 SQ 0.020525 0.012972 0.026612 0 0 0 -1 0 0 80.22
17 P 0 0.698178 1 74.09
18 PY 0
C ===================================================================
C Cranium Outer Surface*
C ===================================================================
74
19 SQ 0.018114 0.011738 0.031888 0 0 0 -1 0 0 80.22
20 SQ 0.018114 0.011738 0.023097 0 0 0 -1 0 0 80.22
21 P 0 .7128927413 1 73.64
C ===================================================================
C 1.3 Teeth *
C ===================================================================
22 SQ 0.051187 0.037998 0 0 0 0 -1 0 -3.81 0





C 1.4 Mandible *
C ===================================================================
27 SQ .02652548037 .3799839648e-1 0 0 0 0 -1 0 -3.81 0
28 SQ .09409462158 .7547397656e-1 0 0 0 0 -1 0 -3.81 0
29 PZ 68
30 SQ .06157294238 .1851080569e-1 0 0 0 0 -1 0 -3.81 0
C ===================================================================
C 1.5 Upper Face Regions *
C ===================================================================
31 SQ 0.022613 0.012237 0 0 0 0 -1 0 0 0
C ===================================================================
C 1.6 Eyes *
C ===================================================================
32 SQ 1 1 1 0 0 0 -1.2996 3.25 -7.06 76.72
33 SQ 1 1 1 0 0 0 -1.2996 -3.25 -7.06 76.72
C ===================================================================
C 1.7 Brain *
C ===================================================================
34 SQ 0.021004 0.013212 0.038903 0 0 0 -1 0 0 80.22
35 SQ 0.021004 0.013212 0.027321 0 0 0 -1 0 0 80.22
36 P 0 0.695402 1 74.17
37 PY 4.12
C ===================================================================
C 1.8 Spine in Head and Neck
C ===================================================================




C 1.9 Sphenoid Sinus * *
C ===================================================================
39 SQ 2.137409801 1.085069445 3.293796794 0 0 0 -1 1.2 -4.8 76.12
40 SQ 2.137409801 1.085069445 3.293796794 0 0 0 -1 -1.2 -4.8 76.12
75
C ===================================================================
C 1.10 Ethmoid Sinus * *
C ===================================================================
41 SQ 8.070764463 1.108033241 1.462140076 0 0 0 -1 1.166 -6.7 76.52
42 SQ 8.070764463 1.108033241 1.462140076 0 0 0 -1 -1.166 -6.7 76.52
C ===================================================================
C 1.11 Frontal Sinus * *
C ===================================================================
C
43 SQ 1.108033241 3.293796794 .5266251124 0 0 0 -1 1.5 -8.1 77.9
44 SQ 1.108033241 3.293796794 .5266251124 0 0 0 -1 -1.5 -8.1 77.9
C
C ===================================================================
C 1.12 Maxillary Sinus*
C ===================================================================
45 S 2.9 -6.2 74.02 1.374
46 S -2.9 -6.2 74.02 1.374
C ===================================================================
C 1.13 Pharynx *
C ===================================================================
47 C/Z 0 1.96 1.08
48 C/Z 0 1.96 0.84
49 PZ 73.55
C




51 C/Z 0 -0.13 0.59
52 C/Z 0 -0.13 0.83
53 PZ 63.67
C
54 C/Z 0 -0.13 0.683
C ===================================================================
C 1.15 Trachea *
C ===================================================================
55 C/Z 0 -0.13 1.0
56 C/Z 0 -0.13 0.74
57 PZ 56.23
C
58 C/Z 0 -0.13 0.793
C ===================================================================
C 1.16 Thyroid **
C ===================================================================
59 C/Z 0 -0.13 1.647
76
60 C/Z 0 -0.13 0.83
61 P .5868986284 -.7168986284 67.3 0 -0.96 64.15 0 -1.98 65.65
62 P -.5868986284 -.7168986284 67.3 0 -0.96 64.15 0 -1.98 65.65
63 P .5868986284 -.7168986284 63.1 0 -0.96 64.15 0 -1.98 63.625








68 P 0 -9.4 77.02 -1.416 -9.235405171 71.97 0 -10.654 74.495
69 P 0 -9.4 77.02 1.416 -9.235405171 71.97 0 -10.654 74.495
70 P 0 -11.528 71.97 -1.416 -9.235405171 71.97 1.416 -9.235405171 71.97
C
71 P 0 -9.78 77.02 -1.796 -9.133757296 71.97 0 -11.034 74.495
72 P 0 -9.78 77.02 1.796 -9.133757296 71.97 0 -11.034 74.495







C 1.19 Salivery Glands
C
C ===================================================================








78 SQ 1.200449511 0.2770083103 0 0 0 0 -1 -1.875 -1.905 71.735
C ===================================================================










81 C/Z -1.75 -2.305 1.495
C ===================================================================













C =============== 2.0 Skeleton* ===================================
C
C ===================================================================
C 2.1 Spine (1983 /C&E)*
C







C 2.2 Ribs (outer surface / inner surface)*
C ===================================================================
90 SQ 92.26 214.92 0 0 0 0 -19806.62 0 0 0






























116 TZ 0 7.22 61.52 15.93 0.7274 0.7274
117 P 6.4852 1 0 7.22
118 P 6.4852 -1 0 -7.22
119 P 0.73137 1 0 7.22
120 P 0.73137 -1 0 -7.22
C
C ===================================================================
C 2.4 Scapulae (inner surface / outer surface)*
C ===================================================================
121 SQ 92.16 267.65 0 0 0 0 -24666.59 0 0 0
122 P 0.28 1 0 0
123 P 0.28 -1 0 0
124 P 0.91 1 0 0






128 SQ 122.54 95.06 0 0 0 0 -11649.4246 0 -3.72 0











C 3.1 Main Bronchi*
C ===================================================================
144 7 CZ 0.741
145 7 CZ 0.504
146 7 PZ 4.92
147 7 PZ -4.92
C
148 8 CZ 0.741
149 8 CZ 0.504
150 8 PZ 4.92
151 8 PZ -4.92
C
152 7 CZ 0.558
153 8 CZ 0.558
C ===================================================================
C 3.2 Lungs*
C (left / right)
C ===================================================================
154 SQ .5977965220e-1 .2052528303e-1 .2367970827e-2 0 0 0 -1 7.33 0 39.21












164 SQ .2921840759 .9425959091 .5948839975e-1 0 0 0 -1 0 -7.15 52
C
C ===================================================================
C 3.4 Heart Model *
C ===================================================================
C basic planes
165 4 PX 0
166 4 PZ 0
C
C right ventricle
167 4 SQ .1618657291e-1 .4788148373e-1 .2441406250e-1 0 0 0 -1 0 0 0




169 4 SQ .1618657291e-1 .4788148373e-1 .1248610921 0 0 0 -1 0 0 0
170 4 SQ .2247751687e-1 .8753194918e-1 .3718024986 0 0 0 -1 0 0 0
C
C left atrium, part 1
171 4 SQ .4097756069e-1 .4788148373e-1 .1248610921 0 0 0 -1 0 0 0
172 4 SQ .04585283989 .5408328825e-1 .1525878906 0 0 0 -1 0 0 0
C
C left atrium, part 2
173 4 SQ .04097756069 .4788148373e-1 .2741152929 0 0 0 -1 0 0 0
174 4 SQ .04585283989 .5408328825e-1 .3718024986 0 0 0 -1 0 0 0
C
C right atrium
175 4 SQ .4097756069e-1 .4788148373e-1 .2441406250e-1 0 0 0 -1 0 0 0








C 4.1 Adrenals (left / right)*
C ===================================================================
177 1 SQ .5917159763 5.408328825 .5408328825e-1 0 0 0 -1 0 0 0




C 4.2 Kidneys (left / right)*
C ===================================================================
C
180 SQ .06096631609 .4271861249 .4064776274e-1 0 0 0 -1 5.18 5.88 29.3








C 4.3 Liver *
C ===================================================================
204 SQ 61.47 201.36 0 0 0 0 -12376.4735 0 0 0






C 4.4 Gall bladder*
C ===================================================================
208 3 SO 1.916
209 3 SO 2.015
210 3 GQ 1 1 -.5175625000e-1 0 0 0 0 0 .8717800000 -3.671056000
211 3 GQ 1 1 -.5175625000e-1 0 0 0 0 0 .9168250000 -4.060225000
212 3 PZ 0
213 3 PZ 7.66
C
C ===================================================================
C 4.5 Pancreas *
C ===================================================================
C






C 4.6 Spleen *
C ===================================================================




C =============== 5.0 Gastrointestinal tract and contents ==========
C
C ===================================================================
C 5.1 Male Esophagus*
C ===================================================================
219 6 CX 0.070
220 SQ 1.417233560 27.70083102 0 0 0 0 -1 0 2.29 0
221 SQ 0.16 1.1025 0 0 0 0 -0.1764 0 2.29 0
222 SQ 0.0144 0.5929 0 0 0 0 -0.00854 0 2.29 0
C
C 409 0.64 cm -¿ 0.5504 cm
223 6 CX 0.5504
224 6 PX 0.0




C 5.2 Stomach *
C ===================================================================
C
226 SQ .1052090140 .1510498950 .2154384531e-1 0 0 0 -1 6.9 -3.92 31.55
227 SQ 437.11 603.135 100.312 0 0 0 -5142.57 6.9 -3.92 31.55
228 SQ 242.612 358.799 45.876 0 0 0 -1998.369 6.9 -3.92 31.55
C
C ===================================================================
C 5.3 S. intestine *
C ===================================================================
C







C 5.4 A. colon*
C ===================================================================
234 SQ .3505425171 .2553338605 0 0 0 0 -1 -7.33 -2.31 0
235 SQ .2143545522 .1666108517 0 0 0 0 -1 -7.33 -2.31 0





C 5.5 T. colon*
C ===================================================================
239 SQ 0 .2278410353 1.010075503 0 0 0 -1 0 -2.31 22.99
240 SQ 0 .1666108517 .5487781425 0 0 0 -1 0 -2.31 22.99





C 5.6 D. colon*
C ===================================================================
244 GQ .7790048836 .4200182372 .1515605581e-1 0 .1494618274 -.7612410830e-1
-10.78635348 -1.174769963 .3180008868 37.15927759
245 GQ .4385772553 .2712673611 .9634411191e-2 0 .9652941682e-1 -.4285762924e-
1
-6.072682475 -.7587212163 .1617163245 20.55160754
246 GQ 1.020304050 .5102040817 .1858708278e-1 0 .1815541031 -.9970378577e-1





C 5.7 S. colon
C ===================================================================
248 TY 1.18 0 7.86 1.18 1.463 0.883
249 TY 4.8336 0 7.86 2.4736 1.463 0.883
C
250 TY 1.18 0 7.86 1.18 1.76 1.18
251 TY 1.18 0 7.86 1.18 1.35 0.77
252 TY 4.8336 0 7.86 2.4736 1.76 1.18






255 SQ .9592869045 .3901371761 0 0 0 0 -1 0 0 0
256 SQ 3.0976 1.3924 0 0 0 0 -4.3131 0 0 0




C =============== 6.0 Lower Chest Organs ==========================
C
C ===================================================================
C 6.1 U. bladder
C ===================================================================
258 SQ 110.4979 176.3504 208.2999 0 0 0 -2014.6979 0 -5.15 7.21
259 SQ 82.3012 135.3779 161.9511 0 0 0 -1343.2970 0 -5.15 7.21






C 8.2.1 Ovaries (left / right)*
C ===================================================================
C Ovaries (left / right)(Shifted -0.1cm x-direction w/ lower abs)
C ===================================================================
272 SQ .7305135510 2.972651605 .3086419754 0 0 0 -1 5.08 0 13.52
273 SQ .7305135510 2.972651605 .3086419754 0 0 0 -1 -5.08 0 13.52
C ===================================================================
C 8.2.2 Uterus *
C ===================================================================
84




C 8.2.3 Breasts *
C ===================================================================
C left















278 SQ 99.4 303.4564 0 0 0 0 -30163.8393 0 0 0
C
C 10.2.2 Female Trunk
C
279 SQ .3423013431e-1 .4331249643e-1 .4715640955e-1 0 0 0 -1 8.63
-8.485408314 46.87
C
280 SQ .3423013431e-1 .4331249643e-1 .4715640955e-1 0 0 0 -1 -8.63
-8.485408314 46.87




C ===== START CHANGES FOR ARMS AND LEGS HERE ========================
C ===================================================================
C
C ====== RIGHT ARM — BONE
289 sph -20.25 0 58.6 2.75
290 trc -20.25 0 58.6 0 0 -31 2.80 2.05
291 sph -20.25 0 27.6 1.95
292 trc -20.25 0 27.6 0 0 -27.3 2.05 1.5
C ======= RIGHT ARM — SOFT TISSUE
293 sph -20.25 0 58.6 4.5
85
294 trc -20.25 0 58.6 0 0 -31 4.55 4.0
295 sph -20.25 0 27.6 4.0
296 trc -20.25 0 27.6 0 0 -27.3 4.0 3.0
C ======= RIGHT ARM — SKIN
297 sph -20.25 0 58.6 4.7
298 trc -20.25 0 58.6 0 0 -31 4.75 4.2
299 sph -20.25 0 27.6 4.2
300 trc -20.25 0 27.6 0 0 -27.3 4.2 3.2
C ====== LEFT ARM — BONE
301 sph 20.25 0 58.6 2.75
302 trc 20.25 0 58.6 0 0 -31 2.80 2.05
303 sph 20.25 0 27.6 1.95
304 trc 20.25 0 27.6 0 0 -27.3 2.05 1.5
C ======= LEFT ARM — SOFT TISSUE
305 sph 20.25 0 58.6 4.5
306 trc 20.25 0 58.6 0 0 -31 4.55 4.0
307 sph 20.25 0 27.6 4.0
308 trc 20.25 0 27.6 0 0 -27.3 4.0 3.0
C ======= LEFT ARM — SKIN
309 sph 20.25 0 58.6 4.7
310 trc 20.25 0 58.6 0 0 -31 4.75 4.2
311 sph 20.25 0 27.6 4.2
312 trc 20.25 0 27.6 0 0 -27.3 4.2 3.2
C
C
C ====== RIGHT LEG — BONE
313 sph -7.7 0.0 -3.01 4.75
314 trc -7.7 0.0 -3.1 0.00 0.00 -36.50 4.5 2.75
315 sph -7.7 0.0 -39.51 2.75
316 trc -7.7 0.0 -39.51 0.00 0.00 -38.70 2.85 1.85
C =======RIGHT LEG – SOFT TISSUE
317 sph -7.7 0 -3.01 7.45
318 trc -7.7 0 -3.1 0.00 0.00 -36.50 7.05 6.05
319 sph -7.7 0.00 -39.51 6.05
320 trc -7.7 0.00 -39.51 0.00 0.00 -38.70 6.05 5.05
C =======RIGHT LEG – SKIN
321 sph -7.7 0 -3.01 7.65
322 trc -7.7 0 -3.1 0.00 0.00 -36.50 7.25 6.25
323 sph -7.7 0.00 -39.51 6.25
324 trc -7.7 0.00 -39.51 0.00 0.00 -38.70 6.25 5.25
C ====== LEFT LEG – BONE
325 sph +7.7 0 -3.01 4.75
326 trc +7.7 0 -3.1 0.00 0.00 -36.50 4.5 2.75
327 sph +7.7 0.0 -39.51 2.75
328 trc +7.7 0.0 -39.51 0.00 0.00 -38.70 2.85 1.85
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C ======= LEFT LEG – SOFT TISSUE
329 sph +7.7 0 -3.01 7.45
330 trc +7.7 0 -3.1 0.00 0.00 -36.50 7.05 6.05
331 sph +7.7 0.0 -39.51 6.05
332 trc +7.7 0.0 -39.51 0.00 0.00 -38.70 6.05 5.05
C ======= LEFT LEG – SKIN
333 sph +7.7 0 -3.01 7.65
334 trc +7.7 0 -3.1 0.00 0.00 -36.50 7.25 6.25
335 sph +7.7 0.0 -39.51 6.25
336 trc +7.7 0.0 -39.51 0.00 0.00 -38.70 6.25 5.25

















c =========== Head and Neck
c ———– Face —————-
501 SQ 0.01731074159 0.01131579724 0 0 0 0 -1 0 0 0
c 502 SQ 0.01811155505 0.01173671946 0 0 0 0 -1 0 0 0
c 503 PY 4.5305
c 504 PY 4.7005
505 PZ 67.2995
c 506 PZ 67.4705
c ——— Top of the Head ——-
508 SQ 0.01731074159 0.01131579724 0.03003081291 0 0 0 -1
0 0 80.22
c ———– Neck —————-
510 SQ 0.99980003 0.99980003 0 0 0 0 -25.0 0 1.78 0
512 PZ 63.1005
c ——– Back of the Head ——-
513 K/Z 0 1.78 42.64099562 0.4112231498E-1
c =========== Nose









778 SQ 99.394053 303.4259656 0 0 0 0 -30163.8393 0 0 0
779 SQ 0.03422380216 0.04330348377 0.04714617096 0 0 0 -1
8.63 -8.485408314 46.86






c ———-Right Arm ———–
797 SPH -20.25 0 58.6 4.7005
798 TRC -20.25 0 58.6 0 0 -31 4.7505 4.2005
799 SPH -20.25 0 27.6 4.2005
800 TRC -20.25 0 27.6 0 0 -27.3 4.2005 3.2005
c ———- Left Arm ———–
809 SPH 20.25 0 58.6 4.7005
810 TRC 20.25 0 58.6 0 0 -31 4.7505 4.2005
811 SPH 20.25 0 27.6 4.2005
812 TRC 20.25 0 27.6 0 0 -27.3 4.2005 3.2005
c =========== Legs
c ———– Right Leg ———-
821 SPH -7.7 0 -3.01 7.6505
822 TRC -7.7 0 -3.1 0 0 -36.50 7.2505 6.2505
823 SPH -7.7 0 -39.51 6.2505
824 TRC -7.7 0 -39.51 0 0 -38.70 6.2505 5.2505
c ———- Left Leg ————
833 SPH 7.7 0 -3.01 7.6505
834 TRC 7.7 0 -3.1 0 0 -36.50 7.2505 6.2505
835 SPH 7.7 0 -39.51 6.2505




c ————— Arms ———————
793 sph -20.25 0 58.6 4.693
794 trc -20.25 0 58.6 0 0 -31 4.743 4.193
795 sph -20.25 0 27.6 4.193
796 trc -20.25 0 27.6 0 0 -27.3 4.193 3.193
88
805 sph 20.25 0 58.6 4.693
806 trc 20.25 0 58.6 0 0 -31 4.743 4.193
807 sph 20.25 0 27.6 4.193




c ———-gas in detector ———-
401 10 RCC 0.6 0 0 1.19 0 0 2.5297
c —– inner detector casing ——–
402 10 RCC 0.4175 0 0 1.5494 0 0 2.6797
c – air cutout in the inner casing –
403 10 RCC 0.4175 0 0 0.05 0 0 2.2225
c —— outer detector head ———
405 10 RCC 0 0 0 2.54 0 0 3.4925
c — air cutout in outer casing —–
406 10 RCC 0 0 0 0.4175 0 0 2.54
c —— detector arm extension ——
407 10 RCC 1.1922 -2.66 0 0 -3.40995 0 0.8025
408 10 RCC 1.1922 -2.91465 0 0 -3.175 0 0.9525
409 10 RCC 1.12 -5.6 0 5.3427 -14.6789 0 0.8025
410 10 RCC 1.12 -5.6 0 5.3427 -14.6789 0 0.9525
c —— nubs on detector head ——–
411 10 RCC 0 3.016 0 -0.17 0 0 0.2
412 10 RCC 0 -3.016 0 -0.17 0 0 0.2
413 10 RCC 0 0 3.016 -0.17 0 0 0.2
414 10 RCC 0 0 -3.016 -0.17 0 0 0.2
c —– extension of inner detector —
415 10 RCC 1.1922 -2.5296 0 0 -0.9629 0 0.485
416 10 RCC 1.1922 -2.5296 0 0 -0.9629 0 0.635
417 10 RCC 1.1922 -3.4925 0 0 -0.8128 0 0.35
418 10 RCC 1.1922 -4.3053 0 0 -0.635 0 0.3175
c —– wire inside the handle ——–
419 10 RCC 1 -4.9403 0 5.5 -15.3386 0 0.01
c ——— wire mesh —————–
420 10 RCC 0.3 -2.52 0.25 0 5.04 0 0.03
421 10 RCC 0.3 -2.45 0.75 0 4.9 0 0.03
422 10 RCC 0.3 -2.2 1.25 0 4.4 0 0.03
423 10 RCC 0.3 -1.85 1.75 0 3.7 0 0.03
424 10 RCC 0.3 -1.15 2.25 0 2.3 0 0.03
425 10 RCC 0.3 -2.52 -0.25 0 5.04 0 0.03
426 10 RCC 0.3 -2.44 -0.75 0 4.88 0 0.03
427 10 RCC 0.3 -2.2 -1.25 0 4.4 0 0.03
428 10 RCC 0.3 -1.85 -1.75 0 3.7 0 0.03
429 10 RCC 0.3 -1.15 -2.25 0 2.3 0 0.03
89
430 10 RCC 0.3 0.25 -2.52 0 0 5.04 0.03
431 10 RCC 0.3 0.75 -2.45 0 0 4.9 0.03
432 10 RCC 0.3 1.25 -2.2 0 0 4.4 0.03
433 10 RCC 0.3 1.75 -1.85 0 0 3.7 0.03
434 10 RCC 0.3 2.25 -1.15 0 0 2.3 0.03
435 10 RCC 0.3 -0.25 -2.52 0 0 5.04 0.03
436 10 RCC 0.3 -0.75 -2.45 0 0 4.9 0.03
437 10 RCC 0.3 -1.25 -2.2 0 0 4.4 0.03
438 10 RCC 0.3 -1.75 -1.85 0 0 3.7 0.03
439 10 RCC 0.3 -2.25 -1.15 0 0 2.3 0.03
c ===================================================================
c Tally Area
900 RCC 23.2 0 13.65 1 0 0 1.784124116
C ===================================================================
C ===================================================================
C =============== Axis Transformation Section * ====================
C ===================================================================
C Adrenals (left / right)
C ===================================================================
TR1 3.22 4.9 34.26 0.5650 0.8251 0 -0.8251 0.5650 0 0 0 1




TR3 -3.98 -3.14 27.04




TR4 0.86 -2.1 45.10





TR6 0 2.29 38.08






*TR7 1.6 -0.13 54 33 90 57 90 0 90 123 90 33






TR10 24.95 0 13.65 1 0 0 0 1 0 0 0 1 1
C ===================================================================
C
C ============= MATERIAL CARDS ======================================
C
C ===================================================================


























































































































































































































































































































C =============== BREAST – Density = 0.94 g/cc =====================
C Composition information from ICRP-89, Table 13.3 on page 244







C GM Detector Materials
M31 10000 0.92 18000 0.075 35000 0.005 $ fill gas
M32 26000 0.75 24000 0.25 $ 446 SS
M33 7000 0.78 8000 0.21 18000 0.01 $Air
M34 13000 1 $ Aluminum
M35 6000 0.856 1000 0.144 $Polyethylene
M36 29000 1 $ Copper
M40 19000 0.043 13000 0.087 14000 0.174 8000 0.522 1000 0.087 9000 0.087
$ Mica
C ===================================================================









C Organ: bone marrow
c (2 3 4 5 $ Cranium and mandible
c 30 29 $ Scapulae and clavicle
c 28 $ ribs
c 31 ) $ pelvis
C Organ: colon
c (57 58 $ right (mucosa+wall)
c 60 61 $ T colon (mucosa+wall)
c 63 64 $ left (mucosa+wall)
c 66 67 $ D colon (mucosa+wall)
c 69 70 $ sigmoid (mucosa+wall)
c 72 73) $ rectum (mucosa+wall)
C Organ: lungs
c (35 36) $ left+right
C Organ: stomach
98
c (53 54) $ mucosa+wall
C Organ: urinary bladder
c (75 76) $ mucosa+wall
C Organ: breast




c (49 $ thoracic portion
c 50 $ abdominal portion




c (1 $ head+neck
c 84) $ trunk
C Organ: bone surface
c (25 26 27 $ C,T,L-spine
c 28 $ ribs
c 29 $ clavicles
c 30 $ scapulae





C Organ: Extrathoracic airways
c (9 $ sinuses
c 12 10 $ pharynx (mucosa+wall)
c 15 13) $ larynx (mucosa+wall)



























FC48 Electron and Photon dermal dose to 10 cm2̂ area
C ===================================================================
C ===== PROBLEM MODE & IMPORTANCES
C ===================================================================
MODE P E
IMP:P 1 173r 0
IMP:E 1 173r 0
C ===================================================================
C ===== SOURCE DESCRIPTION
C ===================================================================
SDEF POS=23.95 0 13.65 RAD=D1 PAR=E ERG=D5 CEL=608
EFF=1E-4
SI1 0 0.2523132522 $ radial limits for source sampling
SP1 -21 2 $ uniform radial probability
si5 H
1.0E-03 1.1E-03 1.2E-03 1.3E-03 1.4E-03 1.5E-03 1.6E-03 1.8E-03
2.0E-03 2.2E-03 2.4E-03 2.6E-03 2.8E-03 3.0E-03 3.2E-03 3.6E-03
4.0E-03 4.5E-03 5.0E-03 5.5E-03 6.0E-03 6.5E-03 7.0E-03 7.5E-03
8.0E-03 8.5E-03 9.0E-03 1.0E-02 1.1E-02 1.2E-02 1.3E-02 1.4E-02
1.5E-02 1.6E-02 1.8E-02 2.0E-02 2.2E-02 2.4E-02 2.6E-02 2.8E-02
3.0E-02 3.2E-02 3.6E-02 4.0E-02 4.5E-02 5.0E-02 5.5E-02 6.0E-02
6.5E-02 7.0E-02 7.5E-02 8.0E-02 8.5E-02 9.0E-02 1.0E-01 1.1E-01
1.2E-01 1.3E-01 1.4E-01 1.5E-01 1.6E-01 1.8E-01 2.0E-01 2.2E-01
2.4E-01 2.6E-01 2.8E-01 3.0E-01 3.2E-01 3.6E-01 4.0E-01 4.5E-01
5.0E-01 5.5E-01 6.0E-01 6.5E-01 7.0E-01 7.5E-01 8.0E-01 8.5E-01
9.0E-01 1.0E+00 1.1E+00 1.176E+00
sp5 D
0.0000E+00 3.5110E-04 3.5100E-04 3.5080E-04 3.5060E-04 3.5040E-04
3.5020E-04 7.0000E-04 6.9920E-04 6.9860E-04 6.9780E-04 6.9700E-04
6.9640E-04 6.9560E-04 6.9480E-04 1.3880E-03 1.3852E-03 1.7275E-03
1.7230E-03 1.7185E-03 1.7140E-03 1.7090E-03 1.7045E-03 1.7000E-03
1.6955E-03 1.6905E-03 1.6860E-03 3.3630E-03 3.3570E-03 3.3510E-03
3.3460E-03 3.3410E-03 3.3360E-03 3.3310E-03 6.6520E-03 6.6300E-03
6.6100E-03 6.5900E-03 6.5700E-03 6.5480E-03 6.5280E-03 6.5080E-03
100
1.2976E-02 1.2896E-02 1.6020E-02 1.5895E-02 1.5775E-02 1.5655E-02
1.5535E-02 1.5420E-02 1.5305E-02 1.5190E-02 1.5080E-02 1.4970E-02
2.9720E-02 2.9280E-02 2.8850E-02 2.8420E-02 2.7980E-02 2.7540E-02
2.7100E-02 5.3300E-02 5.1400E-02 4.9380E-02 4.7180E-02 4.4780E-02
4.2160E-02 3.9260E-02 3.6100E-02 6.5320E-02 5.0200E-02 4.2510E-02
1.8745E-02 3.9955E-03 2.9285E-03 2.7725E-03 2.5955E-03 2.3940E-03
2.1655E-03 1.9095E-03 1.6265E-03 2.6450E-03 1.3830E-03 2.4913E-04
sb5 0.0 82i 1.0
C ===================================================================




c PRDMP 1.0E3 100 0 1
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